Gamma Knife SRS for brain metastases
2018-2024
2024
Homogenous dose prescription in Gamma Knife Radiotherapy: Combining the best of both worlds.
Spaniol M, Abo-Madyan Y, Ruder AM, Fleckenstein J, Giordano FA, Stieler F.Phys Med. 2024 Jan;117:103202. doi: 10.1016/j.ejmp.2023.103202. Epub 2023 Dec 29.PMID: 38159546
Clinically Driven Alpha/Beta Ratios for Melanoma Brain Metastases and Investigation of Biologically Effective Dose as a Predictor for Local Control After Radiosurgery: A Proof of Concept in a Retrospective Longitudinal Series of 274 Consecutive Lesions.
Zubatkina I, Toma-Dasu I, Dasu A, Levivier M, Tuleasca C, Ivanov P.Neurosurgery. 2024 Feb 1;94(2):423-430. doi: 10.1227/neu.0000000000002639. Epub 2023 Sep 4.PMID: 37665222
Plan quality assessment of modern radiosurgery technologies in the treatment of multiple brain metastases.
Hiscoke K, Leong A, Hogan AM, Cowley I.Biomed Phys Eng Express. 2024 Jan 23. doi: 10.1088/2057-1976/ad218f. Online ahead of print.PMID: 38262047
Impact of Clinical Examination and Gamma Knife Surgery in Stage IV Breast Cancer With Brain Metastasis.
Shanbhag NM, Tom MC, Duncan A, Bin Sumaida A.Cureus. 2024 Jan 8;16(1):e51831. doi: 10.7759/cureus.51831. eCollection 2024 Jan.PMID: 38196988
Multi-institutional study of 'Sandwich treatment' for motor area large brain metastases (LBM) with diameter over 3 cm.
Wang Z, Chen H, Chen Q, Zhu Y, Li M, Zhou J.Radiol Oncol. 2024 Jan 6. doi: 10.2478/raon-2024-0002. Online ahead of print.PMID: 38183280
Delayed Imaging Changes 18 Months or Longer After Stereotactic Radiosurgery for Brain Metastases: Necrosis or Progression.
Williams MM, Sohrabi AK, Kittel CA, White JJ, Cramer CK, Lanier CM, Ruiz J, Xing F, Li W, Whitlow CT, Tatter SB, Chan MD, Laxton AW.World Neurosurg. 2024 Jan;181:e453-e458. doi: 10.1016/j.wneu.2023.10.079. Epub 2023 Oct 20.PMID: 37865197
Long-term Survival From Breast Cancer Brain Metastases in the Era of Modern Systemic Therapies.
Mashiach E, Alzate JD, De Nigris Vasconcellos F, Bernstein K, Donahue BR, Schnurman Z, Gurewitz J, Rotman LE, Adams S, Meyers M, Oratz R, Novik Y, Kwa MJ, Silverman JS, Sulman EP, Golfinos JG, Kondziolka D.
2023
The impact of opioid administration for post Gamma Knife radiosurgery frame removal: a prospective quality-improvement study.
Hsieh J, Wei W, Nie JZ, Barnett GH, Mohammadi AM, Stevens G, Vogelbaum M, Angelov L.J Neurooncol. 2023 Sep;164(3):721-728. doi: 10.1007/s11060-023-04436-x. Epub 2023 Sep 25.PMID: 37749305
Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE).
Rusthoven CG, Staley AW, Gao D, Yomo S, Bernhardt D, Wandrey N, El Shafie R, Kraemer A, Padilla O, Chiang V, Faramand AM, Palmer JD, Zacharia BE, Wegner RE, Hattangadi-Gluth JA, Levy A, Bernstein K, Mathieu D, Cagney DN, Chan MD, Grills IS, Braunstein S, Lee CC, Sheehan JP, Kluwe C, Patel S, Halasz LM, Andratschke N, Deibert CP, Verma V, Trifiletti DM, Cifarelli CP, Debus J, Combs SE, Sato Y, Higuchi Y, Aoyagi K, Brown PD, Alami V, Niranjan A, Lunsford LD, Kondziolka D, Camidge DR, Kavanagh BD, Robin TP, Serizawa T, Yamamoto M.J Natl Cancer Inst. 2023 Aug 8;115(8):926-936. doi: 10.1093/jnci/djad073.PMID: 37142267
Outcome of Brain Metastases Treated with Gamma Knife Stereotactic Radiosurgery: A Retrospective Cohort Study of 205 Cases.
Bankole NDA, Melhaoui A, Arkha Y, Afaf S, Bouyakhlef K, Boutarbouch M, Jiddane M, El Khamlichi A.World Neurosurg. 2023 Aug;176:e462-e475. doi: 10.1016/j.wneu.2023.05.083. Epub 2023 May 29.PMID: 37257645
OptImal Gamma kNife lIghTnIng sOlutioN (IGNITION) score to characterize the solution space of the Gamma Knife FIP optimizer for stereotactic radiosurgery.
Tolakanahalli R, Wieczorek DJJ, Lee YC, Tom MC, Hall MD, McDermott MW, Mehta MP, Kotecha R, Gutierrez AN.J Appl Clin Med Phys. 2023 Jun;24(6):e13936. doi: 10.1002/acm2.13936. Epub 2023 Mar 1.PMID: 36855958
Dosimetric evaluation of adult and paediatric brain tumours planned using mask-based cobalt-60 fractionated stereotactic radiotherapy compared to linear accelerator-based volumetric modulated arc therapy.
Fong CH, Heaton R, Liu ZA, Li K, van Prooijen M, Cho YB, Shultz DB, Tsang DS.J Med Radiat Sci. 2023 Mar;70(1):64-71. doi: 10.1002/jmrs.615. Epub 2022 Oct 1.PMID: 36181359
Two-Day Fraction Gamma Knife Radiosurgery for Large Brain Metastasis.
Lee JH, Kim IY, Jung S, Jung TY, Moon KS, Kim YJ, Park SJ, Lim SH.J Korean Neurosurg Soc. 2023 Dec 21. doi: 10.3340/jkns.2023.0214. Online ahead of print.PMID: 38124366
Concomitant radiosurgical and targeted oncological treatment improves the outcome of patients with brain metastases from gastrointestinal cancer.
Khalaveh F, Cho A, Shaltout A, Untersteiner H, Kranawetter B, Hirschmann D, Göbl P, Marik W, Gatterbauer B, Rössler K, Dorfer C, Frischer JM.Radiat Oncol. 2023 Dec 9;18(1):197. doi: 10.1186/s13014-023-02383-5.PMID: 38071299
Predicting the BRAF mutation with pretreatment MRI radiomics features for melanoma brain metastases receiving Gamma Knife radiosurgery.
Kawahara D, Jensen A, Yuan J, Nagata Y, Watanabe Y.Clin Radiol. 2023 Dec;78(12):e934-e940. doi: 10.1016/j.crad.2023.08.012. Epub 2023 Sep 1.PMID: 37690975
Health-related quality of life after stereotactic radiosurgery in patients with brain metastases.
Albers EAC, de Ligt KM, van de Poll-Franse LV, Compter A, de Ruiter MB, Schagen SB.Support Care Cancer. 2023 Nov 27;31(12):720. doi: 10.1007/s00520-023-08203-6.PMID: 38008876
Stereotactic Radiosurgery of Multiple Brain Metastases: A Review of Treatment Techniques.
Bodensohn R, Maier SH, Belka C, Minniti G, Niyazi M.Cancers (Basel). 2023 Nov 14;15(22):5404. doi: 10.3390/cancers15225404.PMID: 38001664
Local control and survival after stereotactic radiosurgery for colorectal cancer brain metastases: an international multicenter analysis.
Bin-Alamer O, Abou-Al-Shaar H, Singh R, Mallela AN, Legarreta A, Bowden G, Mathieu D, Perlow HK, Palmer JD, Elhamdani S, Shepard M, Liang Y, Nabeel AM, Reda WA, Tawadros SR, Abdelkarim K, El-Shehaby AMN, Emad Eldin R, Elazzazi AH, Warnick RE, Gozal YM, Daly M, McShane B, Addis-Jackson M, Karthikeyan G, Smith S, Picozzi P, Franzini A, Kaisman-Elbaz T, Yang HC, Hess J, Templeton K, Zhang X, Wei Z, Pikis S, Mantziaris G, Simonova G, Liscak R, Peker S, Samanci Y, Chiang V, Kersh CR, Lee CC, Trifiletti DM, Niranjan A, Hadjipanayis CG, Lunsford LD, Sheehan JP.J Neurosurg. 2023 Nov 10:1-10. doi: 10.3171/2023.8.JNS231231. Online ahead of print.PMID: 37948682
A brain MRI dataset and baseline evaluations for tumor recurrence prediction after Gamma Knife radiotherapy.
Wang Y, Duggar WN, Caballero DM, Thomas TV, Adari N, Mundra EK, Wang H.Sci Data. 2023 Nov 8;10(1):785. doi: 10.1038/s41597-023-02683-1.PMID: 37938247
A study on inter-planner plan quality variability using a manual planning- or Lightning dose optimizer-approach for single brain lesions treated with the Gamma Knife® Icon™.
Lee YC, Wieczorek DJ, Chaswal V, Kotecha R, Hall MD, Tom MC, Mehta MP, McDermott MW, Gutierrez AN, Tolakanahalli R.J Appl Clin Med Phys. 2023 Nov;24(11):e14088. doi: 10.1002/acm2.14088. Epub 2023 Jul 6.PMID: 37415385
Staged Gamma Knife radiosurgery for a rosette-forming glioneuronal tumor of the fourth ventricle: a case report.
Franzini A, Picozzi P, Lasio GB, Pessina F.Childs Nerv Syst. 2023 Nov;39(11):3323-3326. doi: 10.1007/s00381-023-06014-y. Epub 2023 Jun 5.PMID: 37272935
Overall survival following stereotactic radiosurgery for ten or more brain metastases: a systematic review and meta-analysis.
Rozati H, Chen J, Williams M.BMC Cancer. 2023 Oct 19;23(1):1004. doi: 10.1186/s12885-023-11452-7.PMID: 37858075
Survival and Radiation Dose Differences Between Single Versus Multi-Session Gamma Knife Stereotactic Radiosurgery in Patients Treated for Multiple (≥10) Brain Metastases.
Stambaugh C, Wang AY, Kim E, Mignano JE, Melhus CS, Rodrigues R, Huber K, Stambaugh N, Wu J.Cureus. 2023 Oct 12;15(10):e46901. doi: 10.7759/cureus.46901. eCollection 2023 Oct.PMID: 37954747
Outcomes of Gamma Knife Radiosurgery for Brain Metastases in the Motor Cortex.
Prasad S, Alzate JD, Mullen R, Bernstein K, Qu T, Silverman J, Kondziolka D.Neurosurgery. 2023 Oct 12. doi: 10.1227/neu.0000000000002716. Online ahead of print.PMID: 37823677
'Sandwich treatment' for posterior fossa brain metastases with volume larger than 4cm3: a multicentric retrospective study.
Wang Z, Chen H, Chen Q, Zhu Y, Li M, Jia Z.Clin Exp Metastasis. 2023 Oct;40(5):415-422. doi: 10.1007/s10585-023-10220-y. Epub 2023 Jul 13.PMID: 37439900
Single-Session Gamma Knife Radiosurgery for Patients With 20 or More Brain Metastases.
Wei Z, Luy DD, Jose S, Deng H, Yavan S, Worrell S, Belkhir JR, Tang LW, Niranjan A, Lunsford LD.Neurosurgery. 2023 Oct 1;93(4):857-866. doi: 10.1227/neu.0000000000002482. Epub 2023 Apr 5.PMID: 37018427
The longitudinal risk of hemorrhage of melanoma brain metastases after Gamma Knife radiosurgery.
Hong S, Bouchal SM, Bauman MMJ, Riviere-Cazaux C, Pumford AD, Brown PD, Yan ES, Stafford SL, Markovic SN, Link MJ, Burns TC, Jusue-Torres I, Pollock BE, Parney IF.J Neurosurg. 2023 Sep 29:1-11. doi: 10.3171/2023.7.JNS231225. Online ahead of print.PMID: 37878000
Selected-Lesion Stereotactic Radiosurgery (SL-SRS) as a Novel Strategy in the Treatment of Patients With Multiple Brain Metastases.
Theriault BC, Singh C, Yu J, Knisely J, Shepard M, Wegner RE, Warnick RE, Peker S, Samanci Y, Trifiletti DM, Lee CC, Yang HC, Bernstein K, Kondziolka D, Tripathi M, Mathieu D, Mantziaris G, Pikis S, Sheehan J, Chiang VL.Cureus. 2023 Sep 18;15(9):e45457. doi: 10.7759/cureus.45457. eCollection 2023 Sep.PMID: 37859877
Single-Fraction Versus Fractionated Preoperative Radiosurgery for Resected Brain Metastases: A PROPS-BM International Multicenter Cohort Study.
Prabhu RS, Akinyelu T, Vaslow ZK, Matsui JK, Haghighi N, Dan T, Mishra MV, Murphy ES, Boyles S, Perlow HK, Palmer JD, Udovicich C, Patel TR, Wardak Z, Woodworth GF, Ksendzovsky A, Yang K, Chao ST, Asher AL, Burri SH.Int J Radiat Oncol Biol Phys. 2023 Sep 16:S0360-3016(23)07924-5. doi: 10.1016/j.ijrobp.2023.09.012. Online ahead of print.PMID: 37717787
AI Evaluation of Imaging Factors in the Evolution of Stage-Treated Metastases Using Gamma Knife.
Buzea CG, Buga R, Paun MA, Albu M, Iancu DT, Dobrovat B, Agop M, Paun VP, Eva L.Diagnostics (Basel). 2023 Sep 4;13(17):2853. doi: 10.3390/diagnostics13172853.PMID: 37685391
EGFR-mutated non-small lung cancer brain metastases and radiosurgery outcomes with a focus on leptomeningeal disease.
Alzate JD, Mullen R, Mashiach E, Bernstein K, De Nigris Vasconcellos F, Rotmann L, Berger A, Qu T, Silverman JS, Golfinos JG, Donahue BR, Kondziolka D.J Neurooncol. 2023 Sep;164(2):387-396. doi: 10.1007/s11060-023-04442-z. Epub 2023 Sep 10.PMID: 37691032
Is it advisable to perform radiosurgery for EGFR-TKI-controlled brain metastases? A retrospective study of the role of radiosurgery in lung cancer treatment.
Hung JS, Su YH, Chen CJ, Chiang CL, Shen CI, Yang HC, Shiau CY, Luo YH, Wu HM, Hu YS, Lin CJ, Liu KD, Chung WY, Guo WY, Lee CC.J Neurooncol. 2023 Sep;164(2):413-422. doi: 10.1007/s11060-023-04425-0. Epub 2023 Sep 1.PMID: 37656378
Evaluation of inverse treatment planning for Gamma Knife radiosurgery using fMRI brain activation maps as organs at risk.
Abramian D, Blystad I, Eklund A.Med Phys. 2023 Sep;50(9):5297-5311. doi: 10.1002/mp.16660. Epub 2023 Aug 2.PMID: 37531209
Benchmarking Tests of Contemporary SRS Platforms: Have Technological Developments Resulted in Improved Treatment Plan Quality?
Paddick I, Mott J, Bedford J, Filatov P, Grishchuk D, Orchin G, Houston P, Eaton DJ.Pract Radiat Oncol. 2023 Sep-Oct;13(5):e451-e459. doi: 10.1016/j.prro.2023.05.005. Epub 2023 Jun 7.PMID: 37290672
The long-term course and relationship with survival of multidimensional fatigue in patients with brain metastases after Gamma Knife radiosurgery.
Verhaak E, Schimmel WCM, Sitskoorn MM, Hanssens PEJ, Butterbrod E, Gehring K.J Cancer Res Clin Oncol. 2023 Sep;149(12):9891-9901. doi: 10.1007/s00432-023-04857-1. Epub 2023 May 30.PMID: 37249646
Changes in Gamma Knife Radiosurgery(GKRS)in Patients with Metastatic Brain Tumors before and after COVID-19].
Yamamoto Hattori E, Mori H, Niwa A, Kushi Y, Ozaki S, Shimonaga K, Ikedo T, Hamano E, Yamada K, Imamura H, Iihara K, Kataoka H.Gan To Kagaku Ryoho. 2023 Aug;50(8):881-884.PMID: 37608413
Comparison of preoperative versus postoperative treatment dosimetry plans of single-fraction stereotactic radiosurgery for surgically resected brain metastases.
Cheok SK, Yu C, Feng JJ, Briggs RG, Chow F, Hwang L, Ye JC, Attenello FJ, Tran D, Chang E, Zada G.Neurosurg Focus. 2023 Aug;55(2):E9. doi: 10.3171/2023.5.FOCUS23209.PMID: 37527673
Two-stage radiosurgery for large brain metastases: a systematic review and meta-analysis of clinical outcomes.
Terry F, Merenzon MA, Daggubati L, Zullo K, Levy AS, Bhatia S, Luther E, Komotar RJ, Shah AH, Ivan ME.Neurosurg Focus. 2023 Aug;55(2):E5. doi: 10.3171/2023.5.FOCUS23232.PMID: 37527668
Fractionated versus staged Gamma Knife radiosurgery for mid-to-large brain metastases: a propensity score-matched analysis.
Noda R, Kawashima M, Segawa M, Tsunoda S, Inoue T, Akabane A.J Neurooncol. 2023 Aug;164(1):87-96. doi: 10.1007/s11060-023-04374-8. Epub 2023 Jul 31.PMID: 37525086
Stereotactic radiosurgery for patients with brain metastases from gastroesophageal cancers.
Taori S, Wei Z, Deng H, Hadjipanayis CG, Lunsford LD, Niranjan A.J Neurooncol. 2023 Aug;164(1):147-155. doi: 10.1007/s11060-023-04392-6. Epub 2023 Jul 20.PMID: 37470878
Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial.
Waltenberger M, Bernhardt D, Diehl C, Gempt J, Meyer B, Straube C, Wiestler B, Wilkens JJ, Zimmer C, Combs SE.BMC Cancer. 2023 Jul 29;23(1):709. doi: 10.1186/s12885-023-11202-9.PMID: 37516835
Concurrent Administration of Immune Checkpoint Inhibitors and Single Fraction Stereotactic Radiosurgery in Patients With Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Brain Metastases.
Lehrer EJ, Kowalchuk RO, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, Wei Z, Lunsford LD, Fakhoury KR, Rusthoven CG, Mathieu D, Trudel C, Malouff TD, Ruiz-Garcia H, Bonney P, Hwang L, Yu C, Zada G, Patel S, Deibert CP, Picozzi P, Franzini A, Attuati L, Prasad RN, Raval RR, Palmer JD, Lee CC, Yang HC, Harmsen WS, Jones BM, Sharma S, Ahluwalia MS, Sheehan JP, Trifiletti DM.Int J Radiat Oncol Biol Phys. 2023 Jul 15;116(4):858-868. doi: 10.1016/j.ijrobp.2023.01.017. Epub 2023 Jan 21.PMID: 36690161
Comparing Fractionated and Single-Fraction Gamma Knife Radiosurgery for Brain Metastases From Non-Small-Cell Lung Cancer With a Focus on Driver Alterations.
Kawashima M, Akabane A, Noda R, Segawa M, Tsunoda S, Inoue T.Cureus. 2023 Jul 13;15(7):e41849. doi: 10.7759/cureus.41849. eCollection 2023 Jul.PMID: 37581146
Let's make size not matter: tumor control and toxicity outcomes of hypofractionated Gamma Knife radiosurgery for large brain metastases.
Mishra A, Koffler D, Calugaru E, Rowe N, Viswanatha SD, Begley S, Bajaj V, Schulder M, Goenka A.J Neurooncol. 2023 Jul;163(3):587-595. doi: 10.1007/s11060-023-04365-9. Epub 2023 Jul 6.PMID: 37410346
Brainstem Metastases Treated with Stereotactic Radiosurgery: Masked versus Framed Immobilization.
Begley SL, Goenka A, Schulder M.World Neurosurg. 2023 Jul;175:e1158-e1165. doi: 10.1016/j.wneu.2023.04.085. Epub 2023 Apr 26.PMID: 37116783
Use of stereotactic radiosurgery in treatment of brain metastases from pediatric extracranial solid tumors.
Xu S, Campbell A, Chiang V, Bindra R, Vasquez J, Pashankar F.Pediatr Blood Cancer. 2023 Jul;70(7):e30303. doi: 10.1002/pbc.30303. Epub 2023 Mar 28.PMID: 36975152
Low-Dose Radiosurgery for Brain Metastases in the Era of Modern Systemic Therapy.
Alzate JD, Mashiach E, Berger A, Bernstein K, Mullen R, Nigris Vasconcellos F, Qu T, Silverman JS, Donahue BR, Cooper BT, Sulman EP, Golfinos JG, Kondziolka D.Neurosurgery. 2023 Jun 16. doi: 10.1227/neu.0000000000002556. Online ahead of print.PMID: 37326435
Gamma Knife Radiosurgery Modulates micro-RNA Levels in Patients with Brain Metastasis.
Khan I, Akdur K, Mahfooz S, Elbasan EB, Sakarcan A, Karacam B, Sinclair G, Selek S, Akbas F, Hatiboglu MA.Curr Radiopharm. 2023 Jun 5;16(3):204-213. doi: 10.2174/1874471016666230202164557.PMID: 36733208
Cystic Brain Metastasis Outcomes After Gamma Knife Radiation Therapy.
Amidon RF, Livingston K, Kleefisch CJ, Martens M, Straza M, Puckett L, Schultz CJ, Mueller WM, Connelly JM, Noid G, Morris K, Bovi JA.Adv Radiat Oncol. 2023 Jun 27;9(1):101304. doi: 10.1016/j.adro.2023.101304. eCollection 2024 Jan.PMID: 38260234
Concomitant radiosurgical and targeted oncological treatment improves the outcome of patients with brain metastases from gastrointestinal cancer.
Khalaveh F, Cho A, Shaltout A, Untersteiner H, Kranawetter B, Hirschmann D, Göbl P, Marik W, Gatterbauer B, Rössler K, Dorfer C, Frischer JM.Radiat Oncol. 2023 Dec 9;18(1):197. doi: 10.1186/s13014-023-02383-5.PMID: 38071299
The Role of Stereotactic Radiosurgery in Patients With Brain Metastases From Colorectal Cancers.
Taori S, Wei Z, Deng H, Lunsford LD, Niranjan A.Neurosurgery. 2023 Nov 17. doi: 10.1227/neu.0000000000002749. Online ahead of print.PMID: 37975668
Two fractions staged Gammaknife radiosurgery for "large" cerebral metastases.
Borius PY, Amelot A, Boustany E, Boskos C, Mazeron JJ, Valéry CA.Eur J Surg Oncol. 2023 Nov;49(11):107043. doi: 10.1016/j.ejso.2023.107043. Epub 2023 Aug 22.PMID: 37856987
Modeling Gamma Knife radiosurgical toxicity for multiple brain metastases.
Hsu EJ, Yan Y, Timmerman RD, Wardak Z, Dan TD, Patel TR, Vo DT, Stojadinovic S.Radiother Oncol. 2023 Nov;188:109874. doi: 10.1016/j.radonc.2023.109874. Epub 2023 Aug 26.PMID: 37640162
Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients.
Lehrer EJ, Khosla AA, Ozair A, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, Wei Z, Lunsford LD, Mathieu D, Trudel C, Deibert CP, Malouff TD, Ruiz-Garcia H, Peterson JL, Patel S, Bonney P, Hwang L, Yu C, Zada G, Picozzi P, Franzini A, Attuati L, Prasad RN, Raval RR, Palmer JD, Lee CC, Yang HC, Fakhoury KR, Rusthoven CG, Dickstein DR, Sheehan JP, Trifiletti DM, Ahluwalia MS.J Neurooncol. 2023 Oct;165(1):63-77. doi: 10.1007/s11060-023-04413-4. Epub 2023 Oct 27.PMID: 37889444
Efficacy and safety of a "sandwich therapy" based on staged stereotactic radiosurgery and bevacizumab for large brainstem metastases.
Wang Z, Chen H, Chen Q, Zhu Y, Bai Z, Li M, Zhang W.Clin Neurol Neurosurg. 2023 Oct;233:107911. doi: 10.1016/j.clineuro.2023.107911. Epub 2023 Jul 24.PMID: 37541158
AI Evaluation of Imaging Factors in the Evolution of Stage-Treated Metastases Using Gamma Knife.
Buzea CG, Buga R, Paun MA, Albu M, Iancu DT, Dobrovat B, Agop M, Paun VP, Eva L.Diagnostics (Basel). 2023 Sep 4;13(17):2853. doi: 10.3390/diagnostics13172853.PMID: 37685391
The long-term course and relationship with survival of multidimensional fatigue in patients with brain metastases after Gamma Knife radiosurgery.
Verhaak E, Schimmel WCM, Sitskoorn MM, Hanssens PEJ, Butterbrod E, Gehring K.J Cancer Res Clin Oncol. 2023 Sep;149(12):9891-9901. doi: 10.1007/s00432-023-04857-1. Epub 2023 May 30.PMID: 37249646
A 3-month survival model after Gamma Knife surgery in patients with brain metastasis from lung cancer with Karnofsky performance status ≤ 70.
Park H, Chung HT, Kim JW, Dho YS, Lee EJ.Sci Rep. 2023 Aug 12;13(1):13159. doi: 10.1038/s41598-023-40356-6.PMID: 37573417
Outcome of Brain Metastases Treated with Gamma Knife Stereotactic Radiosurgery: A Retrospective Cohort Study of 205 Cases.
Bankole NDA, Melhaoui A, Arkha Y, Afaf S, Bouyakhlef K, Boutarbouch M, Jiddane M, El Khamlichi A.World Neurosurg. 2023 Aug;176:e462-e475. doi: 10.1016/j.wneu.2023.05.083. Epub 2023 May 29.PMID: 37257645
Comparing Fractionated and Single-Fraction Gamma Knife Radiosurgery for Brain Metastases From Non-Small-Cell Lung Cancer With a Focus on Driver Alterations.
Kawashima M, Akabane A, Noda R, Segawa M, Tsunoda S, Inoue T.Cureus. 2023 Jul 13;15(7):e41849. doi: 10.7759/cureus.41849. eCollection 2023 Jul.PMID: 37581146
Outcomes of single brain metastasis treated with Gamma Knife stereotaxic radiosurgery(GKSR). Our experience on 103 cases.
Bankole NDA, Melhaoui A, Arkha Y, Semmar A, Bouyakhlef K, Jiddane M, El Khamlichi A.IBRO Neurosci Rep. 2023 Jan 26;14:138-145. doi: 10.1016/j.ibneur.2023.01.007. eCollection 2023 Jun.PMID: 36819774
Gamma Knife radiosurgery for gynecologic metastases to the brain: Analysis of pathology, survival, and tumor control.
Wei Z, Luy DD, Tang LW, Deng H, Jose S, Scanlon S, Niranjan A, Lunsford LD.Gynecol Oncol. 2023 May;172:21-28. doi: 10.1016/j.ygyno.2023.03.006. Epub 2023 Mar 14.PMID: 36924726
Up-front single-session radiosurgery for large brain metastases-volumetric responses and outcomes.
Benjamin C, Gurewitz J, Nakamura A, Mureb M, Mullen R, Pacione D, Silverman J, Kondziolka D.Acta Neurochir (Wien). 2023 May;165(5):1365-1378. doi: 10.1007/s00701-023-05491-z. Epub 2023 Jan 27.PMID: 36702970
ISRS Technical Guidelines for Stereotactic Radiosurgery: Treatment of Small Brain Metastases (≤1 cm in Diameter).
Grishchuk D, Dimitriadis A, Sahgal A, De Salles A, Fariselli L, Kotecha R, Levivier M, Ma L, Pollock BE, Regis J, Sheehan J, Suh J, Yomo S, Paddick I.Pract Radiat Oncol. 2023 May-Jun;13(3):183-194. doi: 10.1016/j.prro.2022.10.013. Epub 2022 Nov 24.PMID: 36435388
VEGFR-TKI treatment for radiation-induced brain injury after Gamma Knife radiosurgery for brain metastases from renal cell carcinomas.
Noda R, Akabane A, Kawashima M, Uchino K, Tsunoda S, Segawa M, Inoue T.Jpn J Clin Oncol. 2023 Mar 30;53(4):355-364. doi: 10.1093/jjco/hyac197.PMID: 36579769
Hypo-fractionated Gamma Knife Radiosurgery for Intra-cranial Pathologies: A Single-Center Prospective Analysis of Feasibility, Safety, Efficacy, and Complication Profile.
Tripathi M, Kumar N, Sreenivasan SA, Ahuja CK, Jani P, Bhatta R, Kaur R, Mohindra S, Chauhan R.Neurol India. 2023 Mar-Apr;71(Supplement):S189-S197. doi: 10.4103/0028-3886.373638.PMID: 37026352
Adaptive Staged-Dose Gamma Knife Radiosurgery for the Treatment of Large Brain Metastases: Report of 40 Consecutive Cases and Analysis of Literature.
Crisà FM, Leocata F, Arienti VM, Picano M, Berta L, Brambilla MG, Mainardi HS, Monti AF, Cenzato M, Palazzi M, La Camera A.Neurol India. 2023 Mar-Apr;71(Supplement):S146-S152. doi: 10.4103/0028-3886.373643.PMID: 37026346
Gamma Knife Stereotactic Radiosurgery for Giant Intracranial Tumors - A Series of 70 Patients.
Verma SK, Agrawal D, Santhoor HA, Singh M, Kale SS.Neurol India. 2023 Mar-Apr;71(Supplement):S123-S132. doi: 10.4103/0028-3886.373627.PMID: 37026343
Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS).
Yan M, Lee M, Myrehaug S, Tseng CL, Detsky J, Chen H, Das S, Yeboah C, Lipsman N, Costa LD, Holden L, Heyn C, Maralani P, Ruschin M, Sahgal A, Soliman H.J Neurooncol. 2023 Mar;162(1):119-128. doi: 10.1007/s11060-023-04265-y. Epub 2023 Mar 13.PMID: 36914878
How many brain metastases can be treated with stereotactic radiosurgery before the radiation dose delivered to normal brain tissue rivals that associated with standard whole brain radiotherapy?
Becker SJ, Lipson EJ, Jozsef G, Molitoris JK, Silverman JS, Presser J, Kondziolka D.J Appl Clin Med Phys. 2023 Mar;24(3):e13856. doi: 10.1002/acm2.13856. Epub 2023 Jan 11.PMID: 36628586
Treatment Outcome of Gamma Knife Radiosurgery for Brain Metastasis from Thyroid Cancer: Favorable Local Control but Poor Survival.
Byun J, Song SW, Kim YH, Hong CK, Kim JH, Kim JH.World Neurosurg. 2023 Mar;171:e605-e610. doi: 10.1016/j.wneu.2022.12.070. Epub 2022 Dec 17.PMID: 36535554
Gamma Knife Radiosurgery for Metastatic Brain Tumors from Uterine Cervical and Endometrial Carcinomas: Histopathological Analysis of Survival and Local Control. A Japanese Multi-Institutional Cooperative and Retrospective Cohort Study.
Matsunaga S, Shuto T, Serizawa T, Aoyagi K, Hasegawa T, Kawagishi J, Yomo S, Kenai H, Nakazaki K, Moriki A, Iwai Y, Yamanaka K, Yamamoto T.World Neurosurg. 2023 Mar;171:e572-e580. doi: 10.1016/j.wneu.2022.12.061. Epub 2022 Dec 15.PMID: 36529429
Conservation of pyramidal tract in radiosurgery for brain metastases of lung adenocarcinoma: Three-dimensional analysis of biologically effective dose.
Tang K, Zhang N, Yuan X, Qian Z, Li Y, Feng X.Radiother Oncol. 2023 Feb;179:109451. doi: 10.1016/j.radonc.2022.109451. Epub 2022 Dec 28.PMID: 36586589
Lesion delineation framework for vestibular schwannoma, meningioma and brain metastasis for Gamma Knife radiosurgery using stereotactic magnetic resonance images.
Lee WK, Yang HC, Lee CC, Lu CF, Wu CC, Chung WY, Wu HM, Guo WY, Wu YT.Comput Methods Programs Biomed. 2023 Feb;229:107311. doi: 10.1016/j.cmpb.2022.107311. Epub 2022 Dec 14.
Dosimetric Impact of Lesion Number, Size, and Volume on Mean Brain Dose with Stereotactic Radiosurgery for Multiple Brain Metastases.
La Rosa A, Wieczorek DJJ, Tolakanahalli R, Lee YC, Kutuk T, Tom MC, Hall MD, McDermott MW, Mehta MP, Gutierrez AN, Kotecha R
Gamma Knife Radiosurgery Irradiation of Surgical Cavity of Brain Metastases: Factor Analysis and Gene Mutations.
Huang YH, Yang HC, Chiang CL, Wu HM, Luo YH, Hu YS, Lin CJ, Chung WY, Shiau CY, Guo WY, Lee CC.Life (Basel). 2023 Jan 14;13(1):236. doi: 10.3390/life13010236.PMID: 36676186
2022
A Comparison of Single Fraction and Multi Fraction Radiosurgery on the Gamma Knife ICON: A Single Institution Review.
Loftus JP, Shepard M, Liang Y, Yu A, Karlovits SM, Wegner RE.Adv Radiat Oncol. 2022 Dec 28;8(2):101161. doi: 10.1016/j.adro.2022.101161. eCollection 2023 Mar-Apr.PMID: 36845616
Use of thyroid transcription factor 1 and napsin A to predict local failure and survival after Gamma Knife radiosurgery in patients with brain metastases from lung adenocarcinoma.
Roh H, Lee SY, Lee J, Hwang SY, Kim JH.J Neurosurg. 2022 Aug 12;138(3):663-673. doi: 10.3171/2022.6.JNS22450. Print 2023 Mar 1.PMID: 35962961
Neurocognitive functioning after Gamma Knife and LINAC stereotactic radiosurgery in patients with brain metastases.
Albers EAC, de Ruiter MB, van de Poll-Franse LV, Merckel LG, Compter A, Schagen SB.J Neurooncol. 2022 Dec;160(3):649-658. doi: 10.1007/s11060-022-04185-3. Epub 2022 Dec 1.PMID: 36454373
How to dose-stage large or high-risk brain metastases: an alternative two-fraction radiosurgical treatment approach.
Cho A, Medvedeva K, Kranawetter B, Untersteiner H, Hirschmann D, Lepilina O, Baulin A, Buschmann M, Ertl A, Marik W, Dorfer C, Rössler K, Gatterbauer B, Ilyalov S, Frischer JM.J Neurosurg. 2022 Apr 15;137(6):1666-1675. doi: 10.3171/2022.2.JNS212440. Print 2022 Dec 1.PMID: 35426831
Stereotactic radiosurgery and local control of brain metastases from triple-negative breast cancer.
Kowalchuk RO, Niranjan A, Hess J, Antonios JP, Zhang MY, Braunstein S, Ross RB, Pikis S, Deibert CP, Lee CC, Yang HC, Langlois AM, Mathieu D, Peker S, Samanci Y, Rusthoven CG, Chiang V, Wei Z, Lunsford LD, Trifiletti DM, Sheehan JP.J Neurosurg. 2022 Nov 25:1-7. doi: 10.3171/2022.10.JNS221900. Online ahead of print.PMID: 36433878
Neoadjuvant stereotactic radiosurgery for brain metastases: a new paradigm.
Li YD, Coxon AT, Huang J, Abraham CD, Dowling JL, Leuthardt EC, Dunn GP, Kim AH, Dacey RG, Zipfel GJ, Evans J, Filiput EA, Chicoine MR.Neurosurg Focus. 2022 Nov;53(5):E8. doi: 10.3171/2022.8.FOCUS22367.PMID: 36321291
Volume prediction for large brain metastases after hypofractionated Gamma Knife radiosurgery through artificial neural network.
Moon HC, Park YS.Medicine (Baltimore). 2022 Oct 7;101(40):e30964. doi: 10.1097/MD.0000000000030964.PMID: 36221403
Fractionated Gamma Knife radiosurgery after cyst aspiration for large cystic brain metastases: case series and literature review.
Noda R, Akabane A, Kawashima M, Oshima A, Tsunoda S, Segawa M, Inoue T.Neurosurg Rev. 2022 Oct;45(5):3457-3465. doi: 10.1007/s10143-022-01835-y. Epub 2022 Jul 14.PMID: 35834076
Stereotactic radiosurgery for post operative brain metastasic surgical cavities: a single institution experience.
Cantaloube M, Boucekine M, Balossier A, Muracciole X, Meyer M, Delsanti C, Carron R, Beltaifa YM, Figarella-Branger D, Regis J, Padovani L.Radiat Oncol. 2022 Sep 26;17(1):160. doi: 10.1186/s13014-022-02118-y.PMID: 36163026
Gamma knife icon based hypofractionated stereotactic radiosurgery (GKI-HSRS) for brain metastases: impact of dose and volume.
Yan M, Holden L, Wang M, Soliman H, Myrehaug S, Tseng CL, Detsky J, Ruschin M, Tjong M, Atenafu EG, Das S, Lipsman N, Heyn C, Sahgal A, Husain Z.J Neurooncol. 2022 Sep;159(3):705-712. doi: 10.1007/s11060-022-04115-3. Epub 2022 Aug 24.PMID: 35999435
Interfractional change of tumor volume during fractionated stereotactic radiotherapy using Gamma Knife for brain metastases.
Kawashima M, Akabane A, Noda R, Segawa M, Tsunoda S, Inoue T.J Neurooncol. 2022 Sep;159(2):409-416. doi: 10.1007/s11060-022-04075-8. Epub 2022 Jul 9.PMID: 35809149
Mean Brain Dose Remains Uninfluenced by the Lesion Number for Gamma Knife Stereotactic Radiosurgery for 10+ Metastases.
Sita TL, Gopalakrishnan M, Rooney MK, Ho A, Savoor R, Sonabend AM, Tate MC, Chandler JP, Lesniak MS, Kruser TJ, Kalapurakal JA, Sachdev S.World Neurosurg. 2022 Sep;165:e380-e385. doi: 10.1016/j.wneu.2022.06.057. Epub 2022 Jun 18.PMID: 35724885
Gamma knife radiosurgery for patients with brain metastases from non-small cell lung cancer: Comparison of survival between <5 and ≥5 metastases.
Zhao X, Ding S, Zhang M, Wang C.Thorac Cancer. 2022 Aug;13(15):2152-2157. doi: 10.1111/1759-7714.14532. Epub 2022 Jun 29.PMID: 35770337
Zero Setup Margin Mask versus Frame Immobilization during Gamma Knife® Icon™ Stereotactic Radiosurgery for Brain Metastases.
Kutuk T, Kotecha R, Tolakanahalli R, Wieczorek DJJ, Lee YC, Ahluwalia MS, Hall MD, McDermott MW, Appel H, Gutierrez AN, Mehta MP, Tom MC.Cancers (Basel). 2022 Jul 13;14(14):3392. doi: 10.3390/cancers14143392.PMID: 35884453
Evaluation of Biological Effective Dose in Gamma Knife Staged Stereotactic Radiosurgery for Large Brain Metastases.
Cui T, Weiner J, Danish S, Chundury A, Ohri N, Yue N, Wang X, Nie K.Front Oncol. 2022 Jun 30;12:892139. doi: 10.3389/fonc.2022.892139. eCollection 2022.PMID: 35847934
Clinical outcomes of patients with multiple courses of radiosurgery for brain metastases from non-small cell lung cancer.
Lee WJ, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI.Sci Rep. 2022 Jun 23;12(1):10712. doi: 10.1038/s41598-022-13853-3.PMID: 35739135
A volume matched comparison of survival after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases.
Wei Z, Niranjan A, Abou-Al-Shaar H, Deng H, Albano L, Lunsford LD.J Neurooncol. 2022 May;157(3):417-423. doi: 10.1007/s11060-022-03981-1. Epub 2022 Mar 22.PMID: 3531643
Gamma knife radiosurgery as an efficacious treatment for paediatric central nervous system tumours: a retrospective study of 61 neoplasms.
Mishra H, Pahwa B, Agrawal D, M Ch MS, M Ch SSK.Childs Nerv Syst. 2022 May;38(5):909-918. doi: 10.1007/s00381-022-05463-1. Epub 2022 Mar 15.PMID: 35290486
Metastatic Neoplasm Volume Kinetics Following 2-Stage Stereotactic Radiosurgery.
Damron EP, Dono A, Chafi H, Martir M, Yu TK, Khwaja S, Amsbaugh M, Tandon N, Esquenazi Y, Blanco AI.World Neurosurg. 2022 May;161:e210-e219. doi: 10.1016/j.wneu.2022.01.109. Epub 2022 Feb 3.PMID: 35123024
Quantifying the Sensitivity of Target Dose on Intrafraction Displacement in Intracranial Stereotactic Radiosurgery.
Schasfoort J, Ruschin M, Sahgal A, MacDonald RL, Lee Y, van Pul C, Langenhuizen P, Hanssens P, Beute G, Wittkamper F, Sonke JJ.Pract Radiat Oncol. 2022 May-Jun;12(3):e221-e231. doi: 10.1016/j.prro.2021.11.012. Epub 2021 Dec 17.PMID: 34929403
The modern management of untreated large (>2 cm) brain metastases: a narrative review.
Thomsen BJ, Soliman H.Chin Clin Oncol. 2022 Apr;11(2):16. doi: 10.21037/cco-21-136.PMID: 35534794
Hypofractionated Gamma Knife Radiosurgery: Institutional Experience on Benign and Malignant Intracranial Tumors.
Inserra F, Barone F, Palmisciano P, Scalia G, DA Ros V, Abdelsalam A, Crea A, Sabini MG, Tomasi SO, Ferini G, Maugeri R, Strigari L, Umana GE.Anticancer Res. 2022 Apr;42(4):1851-1858. doi: 10.21873/anticanres.15661.PMID: 35347003
From Postoperative to Preoperative: A Case Series of Hypofractionated and Single-Fraction Neoadjuvant Stereotactic Radiosurgery for Brain Metastases.
Udovicich C, Ng SP, Tange D, Bailey N, Haghighi N.Oper Neurosurg (Hagerstown). 2022 Apr 1;22(4):208-214. doi: 10.1227/ONS.0000000000000101.PMID: 35234410
Multimodality MRI-based radiomics approach to predict the posttreatment response of lung cancer brain metastases to Gamma Knife radiosurgery.
Jiang Z, Wang B, Han X, Zhao P, Gao M, Zhang Y, Wei P, Lan C, Liu Y, Li D.Eur Radiol. 2022 Apr;32(4):2266-2276. doi: 10.1007/s00330-021-08368-w. Epub 2022 Jan 3.PMID: 34978579
Quantitative MR Perfusion for the Differentiation of Recurrence and Radionecrosis in Hypoperfusion and Hyperperfusion Brain Metastases After Gamma Knife Radiosurgery.
Yunqi Y, Aihua N, Zhiming Z, Yingchao L, Qiang W, Yang M, Yi Z.Front Neurol. 2022 Mar 18;13:823731. doi: 10.3389/fneur.2022.823731. eCollection 2022.PMID: 35370912
The efficacy of EGFR-tyrosine kinase inhibitor in non-small cell lung cancer patients with synchronous brain metastasis: a real-world study.
Choi JH, Choi YW, Lee HW, Kang SY, Jeong GS, Ahn MS, Oh YT, Noh OK, Kim SH, Roh TH, Sheen SS.Korean J Intern Med. 2022 Mar;37(2):434-443. doi: 10.3904/kjim.2021.315. Epub 2022 Feb 16.PMID: 35167736
Reirradiation With Stereotactic Radiosurgery After Local or Marginal Recurrence of Brain Metastases From Previous Radiosurgery
Kowalchuk RO, Niranjan A, Lee CC, Yang HC, Liscak R, Guseynova K, Tripathi M, Kumar N, Peker S, Samanci Y, Hess J, Chiang V, Iorio-Morin C, Mathieu D, Pikis S, Wei Z, Lunsford LD, Trifiletti DM, Sheehan JP.Int J Radiat Oncol Biol Phys. 2022 Mar 1;112(3):726-734. doi: 10.1016/j.ijrobp.2021.10.008. Epub 2021 Oct 10.PMID: 34644606
Histopathology and surgical outcome of symptomatic treatment-related changes after Gamma Knife radiosurgery in patients with brain metastases.
Kim JH, Choi JW, Kong DS, Seol HJ, Nam DH, Ryu JW, Kim ST, Suh YL, Lee JI.Sci Rep. 2022 Feb 22;12(1):3013. doi: 10.1038/s41598-022-06881-6.PMID: 35194082
Gamma Knife radiosurgery for metastatic brain tumors from ovarian cancer: histopathological analysis of survival and local control. A Japanese multi-institutional cooperative and retrospective cohort study.
Matsunaga S, Shuto T, Serizawa T, Aoyagi K, Hasegawa T, Kawagishi J, Yomo S, Kenai H, Nakazaki K, Moriki A, Iwai Y, Yamamoto T.J Neurosurg. 2022 Feb 11:1-9. doi: 10.3171/2021.12.JNS212239. Online ahead of print.PMID: 35148503
Influence of temporal muscle thickness on the outcome of radiosurgically treated patients with brain metastases from non-small cell lung cancer.
Cho A, Hennenberg J, Untersteiner H, Hirschmann D, Gatterbauer B, Zöchbauer-Müller S, Hochmair MJ, Preusser M, Rössler K, Dorfer C, Frischer JM, Furtner J.J Neurosurg. 2022 Feb 4:1-7. doi: 10.3171/2021.12.JNS212193. Online ahead of print.PMID: 35120324
Cerebral metastases.
Ganz JC.Prog Brain Res. 2022;268(1):229-258. doi: 10.1016/bs.pbr.2021.10.034. Epub 2022 Jan 13.PMID: 35074082
Mask-Based versus Frame-Based Gamma Knife ICON Radiosurgery in Brain Metastases: A Prospective Randomized Trial.
Régis J, Merly L, Balossier A, Baumstarck K, Hamdi H, Mariani S, Delsanti C, Vincent M, Nigoul JM, Beltaifa Y, Muracciole X.Stereotact Funct Neurosurg. 2022;100(2):86-94. doi: 10.1159/000519280. Epub 2021 Dec 21.PMID: 34933308 Clinical Trial.
Is Real-Time Inverse Planning Optimizing Dose to the Normal Brain? A Prospective Comparative Trial in a Series of Brain Metastases Treated by Stereotactic Radiosurgery.
Beltaifa Y, Hamdi H, Spatola G, Balossier A, Merly L, Castillo L, Cretol A, Regis J.Stereotact Funct Neurosurg. 2022;100(1):53-60. doi: 10.1159/000519024. Epub 2021 Nov 24.PMID: 34818656
Radiologic and Clinical Outcomes of Stereotactic Radiosurgery for Intraventricular Metastases.
Mantziaris G, Pikis S, Marquis O, Sheehan J.World Neurosurg. 2022 Jan;157:e333-e341. doi: 10.1016/j.wneu.2021.10.083. Epub 2021 Oct 12.PMID: 34653703
Use of predictive spatial modeling to reveal that primary cancers have distinct central nervous system topography patterns of brain metastasis.
Neman J, Franklin M, Madaj Z, Deshpande K, Triche TJ, Sadlik G, Carmichael JD, Chang E, Yu C, Strickland BA, Zada G.
2021
Single Fraction Frameless Stereotactic Radiosurgery on the Gamma Knife Icon for Patients With Brain Metastases: Time to Abandon the Frame?
Wegner RE, Horne ZD, Liang Y, Goss M, Yu A, Pace J, Williamson RW, Leonardo J, Karlovits SM, Fuhrer R.Adv Radiat Oncol. 2021 Jun 6;6(5):100736. doi: 10.1016/j.adro.2021.100736. eCollection 2021 Sep-Oct.PMID: 34646964
Survival and outcomes in patients with ≥ 25 cumulative brain metastases treated with stereotactic radiosurgery.
Benjamin CG, Gurewitz J, Kavi A, Bernstein K, Silverman J, Mureb M, Donahue B, Kondziolka D.J Neurosurg. 2021 Dec 24:1-11. doi: 10.3171/2021.9.JNS21882. Online ahead of print.PMID: 34952524
Combined stereotactic radiosurgery and tyrosine kinase inhibitor therapy versus tyrosine kinase inhibitor therapy alone for the treatment of non-small cell lung cancer patients with brain metastases.
Chiou GY, Chiang CL, Yang HC, Shen CI, Wu HM, Chen YW, Chen CJ, Luo YH, Hu YS, Lin CJ, Chung WY, Shiau CY, Guo WY, Pan DH, Lee CC.J Neurosurg. 2021 Dec 17:1-8. doi: 10.3171/2021.9.JNS211373. Online ahead of print.PMID: 34920439
Staged radiosurgery alone versus postoperative cavity radiosurgery for patients with midsize-to-large brain metastases: a propensity score matching analysis.
Yomo S, Yako T, Kitazawa K, Oguchi K.J Neurosurg. 2021 Dec 17:1-8. doi: 10.3171/2021.9.JNS211797. Online ahead of print.PMID: 34920421
Outcomes of Gamma Knife Radiosurgery for Brain Metastases From Anaplastic Lymphoma Kinase Rearrangement-Positive and EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Matsunaga S, Shuto T.Cureus. 2021 Dec 13;13(12):e20398. doi: 10.7759/cureus.20398. eCollection 2021 Dec.PMID: 3504724
Resecting the dominant lesion: Patient outcomes after surgery and radiosurgery vs stand-alone radiosurgery in the setting of multiple brain metastases.
Punchak M, Miranda SP, Gutierrez A, Brem S, O'Rourke D, Lee JYK, Shabason JE, Petrov D.Clin Neurol Neurosurg. 2021 Dec;211:107016. doi: 10.1016/j.clineuro.2021.107016. Epub 2021 Nov 4.PMID: 34823154
Stereotactic Radiosurgery Results for Patients With Brain Metastases From Gastrointestinal Cancer: A Retrospective Cohort Study of 802 Patients With GI-GPA Validity Test.
Yamamoto M, Serizawa T, Sato Y, Higuchi Y, Kawabe T, Kasuya H, Barfod BE.Adv Radiat Oncol. 2021 May 18;6(6):100721. doi: 10.1016/j.adro.2021.100721. eCollection 2021 Nov-Dec.PMID: 34934852
The Tumor Control According to Radiation Dose of Gamma Knife Radiosurgery for Small and Medium-Sized Brain Metastases from Non-Small Cell Lung Cancer.
Park SJ, Lim SH, Kim YJ, Moon KS, Kim IY, Jung S, Kim SK, Oh IJ, Hong JH, Jung TY.J Korean Neurosurg Soc. 2021 Nov;64(6):983-994. doi: 10.3340/jkns.2021.0165. Epub 2021 Oct 25.PMID: 34689476
Stereotactic radiosurgery in alveolar soft part sarcoma brain metastases: Case series and literature review.
Lim JX, Karlsson B, Pang A, Vellayappan BA, Nga V.J Clin Neurosci. 2021 Nov;93:227-230. doi: 10.1016/j.jocn.2021.09.002. Epub 2021 Sep 24.PMID: 34656252
Outcomes after stereotactic radiosurgery of brain metastases in patients with malignant melanoma and validation of the melanoma molGPA.
Kessel KA, Deichl A, Gempt J, Meyer B, Posch C, Diehl C, Zimmer C, Combs SE.Clin Transl Oncol. 2021 Oct;23(10):2020-2029. doi: 10.1007/s12094-021-02607-8. Epub 2021 May 15.PMID: 33993415
Low-Dosage Bevacizumab Treatment: Effect on Radiation Necrosis After Gamma Knife Radiosurgery for Brain Metastases.
Weng Y, Shen J, Zhang L, Fang Z, Xiao F, Zhang C, Fan Z, Huang K, Wang L, Huang B, Wu F, Zhang T, Xu Q.Front Surg. 2021 Sep 3;8:720506. doi: 10.3389/fsurg.2021.720506. eCollection 2021.PMID: 34540887
Stereotactic radiosurgery for the treatment of esophageal carcinoma brain metastases.
Zheng C, Weng Y, Xu Q.J BUON. 2021 Sep-Oct;26(5):2126-2130.PMID: 34761626
Predicting local failure of brain metastases after stereotactic radiosurgery with radiomics on planning MR images and dose maps.
Wang H, Xue J, Qu T, Bernstein K, Chen T, Barbee D, Silverman JS, Kondziolka D.Med Phys. 2021 Sep;48(9):5522-5530. doi: 10.1002/mp.15110. Epub 2021 Jul 31.PMID: 34287940
Stereotactic Radiosurgery for Postoperative Metastatic Surgical Cavities: A Critical Review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines.
Redmond KJ, De Salles AAF, Fariselli L, Levivier M, Ma L, Paddick I, Pollock BE, Regis J, Sheehan J, Suh J, Yomo S, Sahgal A.Int J Radiat Oncol Biol Phys. 2021 Sep 1;111(1):68-80. doi: 10.1016/j.ijrobp.2021.04.016. Epub 2021 Apr 20.PMID: 33891979
Prognostic value of pretreatment MRI texture features in breast cancer brain metastasis treated with Gamma Knife radiosurgery.
Zheng Y, Geng D, Yu T, Xia W, She D, Liu L, Yin B.Acta Radiol. 2021 Sep;62(9):1208-1216. doi: 10.1177/0284185120956296. Epub 2020 Sep 10.PMID: 32910684
Gamma Knife Radiosurgery-Based Combination Treatment Strategies Improve Survival in Patients With Central Nervous System Metastases From Epithelial Ovarian Cancer: A Retrospective Analysis of Two Academic Institutions in Korea and Taiwan.
Lai YL, Kang JH, Hsu CY, Lee JI, Cheng WF, Chen YL, Lee YY.Front Oncol. 2021 Aug 27;11:719936. doi: 10.3389/fonc.2021.719936. eCollection 2021.PMID: 34513698
Enhancement of Radiosurgical Treatment Outcome Prediction Using MRI Radiomics in Patients with Non-Small Cell Lung Cancer Brain Metastases.
Liao CY, Lee CC, Yang HC, Chen CJ, Chung WY, Wu HM, Guo WY, Liu RS, Lu CF.Cancers (Basel). 2021 Aug 10;13(16):4030. doi: 10.3390/cancers13164030.PMID: 34439186
Dosimetric Comparison, Treatment Efficiency Estimation, and Biological Evaluation of Popular Stereotactic Radiosurgery Options in Treating Single Small Brain Metastasis.
Duan Y, Cao H, Wu B, Wu Y, Liu D, Zhou L, Feng A, Wang H, Chen H, Gu H, Shao Y, Huang Y, Lin Y, Ma K, Fu X, Fu H, Kong Q, Xu Z.Front Oncol. 2021 Aug 5;11:716152. doi: 10.3389/fonc.2021.716152. eCollection 2021.PMID: 34540686
Nivolumab and Gamma Knife Radiosurgery for a Gastric Cancer Patient with Brain Metastasis-A Case Report].
Yamamoto H, Tanabe S, Ishida Y, Sato H, Takezawa A, Furukawa K, Nakae H, Kobayashi T, Inase M.Gan To Kagaku Ryoho. 2021 Jul;48(7):963-965.PMID: 34267037
Validation of the updated renal graded prognostic assessment (GPA) for patients with renal cancer brain metastases treated with Gamma Knife radiosurgery.
van Ruitenbeek NJ, Ho VKY, Westgeest HM, Beerepoot LV, Hanssens PEJ.J Neurooncol. 2021 Jul;153(3):527-536. doi: 10.1007/s11060-021-03793-9. Epub 2021 Jun 25.PMID: 34170460
Neutrophil-to-Lymphocyte Ratio Is Superior to Other Leukocyte-Based Ratios as a Prognostic Predictor in Non-Small Cell Lung Cancer Patients with Radiosurgically Treated Brain Metastases Under Immunotherapy or Targeted Therapy.
Cho A, Kranawetter B, Untersteiner H, Khalaveh F, Dorfer C, Rössler K, Zöchbauer-Müller S, Gatterbauer B, Hochmair MJ, Frischer JM.World Neurosurg. 2021 Jul;151:e324-e331. doi: 10.1016/j.wneu.2021.04.033. Epub 2021 Apr 18.PMID: 33878466
Prognostic Factors for Patients With Brain Metastases Treated With Single-fraction Gamma Knife Radiosurgery.
Noyama T, Katano A, Shinya Y, Kawashima M, Shin M, Saito N, Yamashita H.Anticancer Res. 2021 Jun;41(6):3179-3185. doi: 10.21873/anticanres.15104.PMID: 34083313
Single-fraction versus hypofractionated Gamma Knife radiosurgery for small metastatic brain tumors.
Samanci Y, Karakose F, Senyurek S, Peker S.Clin Exp Metastasis. 2021 Jun;38(3):305-320. doi: 10.1007/s10585-021-10086-y. Epub 2021 Mar 17.PMID: 33733707
Group and Individual Change in Cognitive Functioning in Patients With 1 to 10 Brain Metastases Following Gamma Knife Radiosurgery.
Schimmel WCM, Verhaak E, Bakker M, Hanssens PEJ, Sitskoorn MM, Gehring K.Clin Oncol (R Coll Radiol). 2021 May;33(5):314-321. doi: 10.1016/j.clon.2021.01.003. Epub 2021 Jan 30.PMID: 33531195
Cognitive Functioning and Health-Related Quality of Life of Long-Term Survivors With Brain Metastases Up to 21 Months After Gamma Knife Radiosurgery.
Verhaak E, Schimmel WCM, Gehring K, Hanssens PEJ, Sitskoorn MM.Neurosurgery. 2021 Apr 15;88(5):E396-E405. doi: 10.1093/neuros/nyaa586.PMID: 33575811
A general algorithm for distributed treatments of multiple brain metastases.
Chen M, Wardak Z, Stojadinovic S, Gu X, Lu W.Med Phys. 2021 Apr;48(4):1832-1838. doi: 10.1002/mp.14722. Epub 2021 Feb 22.PMID: 33449357
Safety and efficacy of upfront stereotactic radiosurgery for brain metastases with high cumulative intracranial tumor volume (> 7 ml): analysis of 233 consecutive patients.
Yomo S, Oda K, Oguchi K.Acta Neurochir (Wien). 2021 Apr;163(4):991-1001. doi: 10.1007/s00701-020-04658-2. Epub 2021 Jan 4.PMID: 33398539
Expanded Radiosurgery Capabilities Utilizing Gamma Knife® Icon™.
Mendel JT, Schroeder S, Plitt A, Patel A, Joo M, Stojadinovic S, Dan T, Timmerman R, Patel TR, Wardak Z.Cureus. 2021 Mar 19;13(3):e13998. doi: 10.7759/cureus.13998.PMID: 33758727
Treating Choroidal Metastases and Improving Vision with Osimertinib in EGFR T790M-Mutated Lung Adenocarcinoma: A Case Report and Review of the Literature.
Keshwani K, Roelofs KA, Hay G, Lewis R, Plowman N.Ocul Oncol Pathol. 2021 Mar;7(1):26-30. doi: 10.1159/000510602. Epub 2020 Oct 28.PMID: 33796513
Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery.
Lee MH, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Jung HA, Sun JM, Lee SH, Ahn JS, Ahn MJ, Park K, Lee JI.J Korean Neurosurg Soc. 2021 Mar;64(2):271-281. doi: 10.3340/jkns.2020.0135. Epub 2020 Dec 4.PMID: 33267531
A graded prognostic model for patients surviving 3 years or more (GPM ≥ 3Ys) after stereotactic radiosurgery for brain metastasis.
Sato Y, Yamamoto M, Serizawa T, Yamada KI, Higuchi Y, Kasuya H.Radiother Oncol. 2021 Mar;156:29-35. doi: 10.1016/j.radonc.2020.11.024. Epub 2020 Nov 27.PMID: 33249092
Dosimetric study between a single isocenter dynamic conformal arc therapy technique and Gamma Knife radiosurgery for multiple brain metastases treatment: impact of target volume geometrical characteristics.
Chea M, Fezzani K, Jacob J, Cuttat M, Croisé M, Simon JM, Feuvret L, Valery CA, Maingon P, Benadjaoud MA, Jenny C.Radiat Oncol. 2021 Feb 27;16(1):45. doi: 10.1186/s13014-021-01766-w.PMID: 33639959
Hypofractionated frameless Gamma Knife radiosurgery for large metastatic brain tumors.
Samanci Y, Sisman U, Altintas A, Sarioglu S, Sharifi S, Atasoy Aİ, Bolukbasi Y, Peker S.Clin Exp Metastasis. 2021 Feb;38(1):31-46. doi: 10.1007/s10585-020-10068-6. Epub 2021 Jan 3.PMID: 33389335
The Use of Treatment Response Assessment Maps in Discriminating Between Radiation Effect and Persistent Tumoral Lesion in Metastatic Brain Tumors Treated with Gamma Knife Radiosurgery.
Peker S, Samanci Y, Aygun MS, Yavuz F, Erden ME, Nokay AE, Atasoy Aİ, Bolukbasi Y.World Neurosurg. 2021 Feb;146:e1134-e1146. doi: 10.1016/j.wneu.2020.11.114. Epub 2020 Nov 27.PMID: 33253956
Early Magnetic Resonance Imaging After Gamma Knife Radiosurgery of Brain Metastases.
Benveniste RJ, Yechieli R, Diwanji T.World Neurosurg. 2021 Feb;146:e1177-e1181. doi: 10.1016/j.wneu.2020.11.119. Epub 2020 Nov 27.PMID: 33253947
Stereotactic Radiosurgery Results for Patients with 5-10 versus 11-20 Brain Metastases: A Retrospective Cohort Study Combining 2 Databases Totaling 2319 Patients.
Yamamoto M, Serizawa T, Sato Y, Higuchi Y, Kasuya H.World Neurosurg. 2021 Feb;146:e479-e491. doi: 10.1016/j.wneu.2020.10.124. Epub 2020 Nov 16.PMID: 33212279
Metastatic renal cell carcinoma to the brain: optimizing patient selection for Gamma Knife radiosurgery.
Stenman M, Benmakhlouf H, Wersäll P, Johnstone P, Hatiboglu MA, Mayer-da-Silva J, Harmenberg U, Lindskog M, Sinclair G.Acta Neurochir (Wien). 2021 Feb;163(2):333-342. doi: 10.1007/s00701-020-04537-w. Epub 2020 Sep 9.PMID: 32902689
Stereotactic cyst aspiration directly followed by Gamma Knife radiosurgery for large cystic brain metastases.
Sadik ZHA, Hanssens PEJ, Verheul JB, Ardon H, Lie ST, van der Pol B, Beute GN, Fleischeuer REM, Leenstra S.Acta Neurochir (Wien). 2021 Feb;163(2):343-350. doi: 10.1007/s00701-020-04273-1. Epub 2020 Apr 14.PMID: 32291592
Predicting the Local Response of Metastatic Brain Tumor to Gamma Knife Radiosurgery by Radiomics With a Machine Learning Method.
Kawahara D, Tang X, Lee CK, Nagata Y, Watanabe Y.Front Oncol. 2021 Jan 11;10:569461. doi: 10.3389/fonc.2020.569461. eCollection 2020.PMID: 33505904
Possible Overcoming of Tumor Hypoxia with Adaptive Hypofractionated Radiosurgery of Large Brain Metastases: A Biological Modeling Study.
Ma L, Tseng CL, Sahgal A.Acta Neurochir Suppl. 2021;128:107-112. doi: 10.1007/978-3-030-69217-9_11.PMID: 34191066
Redistributing Central Target Dose Hot Spots for Hypofractionated Radiosurgery of Large Brain Tumors: A Proof-of-Principle Study.
Ma L, Braunstein SE, Golden E, Fogh S, Nakamura J, McDermott MW, Sneed PK.Acta Neurochir Suppl. 2021;128:101-106. doi: 10.1007/978-3-030-69217-9_10.PMID: 34191065
Simultaneous Truth and Performance Level Estimation Method for Evaluation of Target Contouring in Radiosurgery.
SandstrÖm H, Toma-Dasu I, Chung C, GÅrding J, Jokura H, Dasu A.Anticancer Res. 2021 Jan;41(1):279-288. doi: 10.21873/anticanres.14774.PMID: 33419822
Mask-based immobilization in Gamma Knife stereotactic radiosurgery.
Bush A, Vallow L, Ruiz-Garcia H, Herchko S, Reimer R, Ko S, May B, Trifiletti DM, Peterson J.J Clin Neurosci. 2021 Jan;83:37-42. doi: 10.1016/j.jocn.2020.11.033. Epub 2020 Dec 15.PMID: 33339692
Pre-radiosurgery leucocyte ratios and modified glasgow prognostic score predict survival in non-small cell lung cancer brain metastases patients.
Cho A, Untersteiner H, Hirschmann D, Fitschek F, Dorfer C, Rössler K, Zöchbauer-Müller S, Gatterbauer B, Hochmair MJ, Frischer JM.J Neurooncol. 2021 Jan;151(2):257-265. doi: 10.1007/s11060-020-03660-z. Epub 2020 Nov 11.PMID: 33179214
2020
Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases.
Int J Radiat Oncol Biol Phys. 2020 Dec 31. pii: S0360-3016(20)34451-5.
Redmond KJ, Gui C, Benedict S, Milano MT, Grimm J, Vargo JA, Soltys SG, Yorke E, Jackson A, El Naqa I, Marks LB, Xue J, Heron DE, Kleinberg LR
PMID: 33390244 DOI: 10.1016/j.ijrobp.2020.10.034
Internal dose escalation associated with increased local control for melanoma brain metastases treated with stereotactic radiosurgery.
J Neurosurg. 2020 Dec 11:1-7.
Kennedy WR, DeWees TA, Acharya S, Mahmood M, Knutson NC, Goddu SM, Kavanaugh JA, Mitchell TJ, Rich KM, Kim AH, Leuthardt EC, Dowling JL, Dunn GP, Chicoine MR, Perkins SM, Huang J, Tsien CI, Robinson CG, Abraham CD
PMID: 33307528 DOI: 10.3171/2020.7.JNS192210
Dosimetric predictors of symptomatic radiation necrosis after five-fraction radiosurgery for brain metastases.
Radiother Oncol. 2020 Dec 10. pii: S0167-8140(20)31230-5.
Andruska N, Kennedy WR, Bonestroo L, Anderson R, Huang Y, Robinson CG, Abraham C, Tsien C, Knutson N, Rich KM, Spencer C, Huang J
PMID: 33310010 DOI: 10.1016/j.radonc.2020.12.011
Gamma Knife Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy or Targeted Therapy.
Cancers (Basel). 2020 Dec 7;12(12). pii: cancers12123668.
Cho A, Untersteiner H, Hirschmann D, Shaltout A, Gobl P, Dorfer C, Rossler K, Marik W, Kirchbacher K, Kapfhammer I, Zochbauer-Muller S, Gatterbauer B, Hochmair MJ, Frischer JM
PMID: 33297416 DOI: 10.3390/cancers12123668
Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery.
J Korean Neurosurg Soc. 2020 Dec 4. pii: jkns.2020.0135.
Lee MH, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Jung HA, Sun JM, Lee SH, Ahn JS, Ahn MJ, Park K, Lee JI
PMID: 33267531 DOI: 10.3340/jkns.2020.0135
Early magnetic resonance imaging after Gamma Knife radiosurgery of brain metastases.
World Neurosurg. 2020 Nov 27. pii: S1878-8750(20)32504-3.
Benveniste RJ, Yechieli R, Diwanji T
PMID: 33253947 DOI: 10.1016/j.wneu.2020.11.119
The Utilization of Treatment Response Assessment Maps in Discriminating Between Radiation Effect and Persistent Tumoral Lesion in Metastatic Brain Tumors Treated with Gamma Knife Radiosurgery.
World Neurosurg. 2020 Nov 27. pii: S1878-8750(20)32499-2.
Peker S, Samanci Y, Serhat Aygun M, Yavuz F, Emre Erden M, Emre Nokay A, Ihsan Atasoy A, Bolukbasi Y
PMID: 33253956 DOI: 10.1016/j.wneu.2020.11.114
A graded prognostic model for patients surviving 3 years or more (GPM>/=3Ys) after stereotactic radiosurgery for brain metastasis.
Sato Y, et al. Radiother Oncol. 2021. PMID: 33249092
Health-related quality of life after Gamma Knife radiosurgery in patients with 1-10 brain metastases.
J Cancer Res Clin Oncol. 2020 Oct 6. pii: 10.1007/s00432-020-03400-w. Verhaak E, Schimmel WCM, Gehring K, Emons WHM, Hanssens PEJ, Sitskoorn MM
PMID: 33025282 DOI: 10.1007/s00432-020-03400-w
The Effect of Epidermal Growth Factor Receptor Mutation on Intracranial Progression-Free Survival of Non-Small Cell Lung Cancer Patients with Brain Metastasis Underwent Gamma Knife Radiosurgery.
Brain Tumor Res Treat. 2020 Oct;8(2):103-108. Yang SH, Kim HY, Lee SI, Jin SJ
PMID: 33118342 DOI: 10.14791/btrt.2020.8.e15
Radiosurgery for small-cell lung cancer brain metastases: a review.
J Thorac Dis. 2020 Oct;12(10):6234-6239.
Robin TP, Rusthoven CG
PMID: 33209462 DOI: 10.21037/jtd.2020.03.90
Impact of Systemic Therapy Type and Timing on Intracranial Tumor Control in Patients with Brain Metastasis from Non-Small Cell Lung Cancer Treated With Stereotactic Radiosurgery.
World Neurosurg. 2020 Sep 18. pii: S1878-8750(20)32090-8. Singh SA, McDermott DM, Mattes MD
PMID: 32956881 DOI: 10.1016/j.wneu.2020.09.082
Role of Gamma Knife Radiosurgery in Small Cell Lung Cancer: A Multi- Institutional Retrospective Study of the International Radiosurgery Research Foundation (IRRF).
Neurosurgery. 2020 Sep 15;87(4):664-671.
Cifarelli CP, Vargo JA, Fang W, Liscak R, Guseynova K, Warnick RE, Lee CC, Yang HC, Borghei-Razavi H, Maiti T, Siddiqui ZA, Yuan JC, Grills IS, Mathieu D, Touchette CJ, Cordeiro D, Chiang V, Hess J, Tien CJ, Faramand A, Kano H, Barnett GH, Sheehan JP, Lunsford LD
PMID: 31599324 DOI: 10.1093/neuros/nyz428
Prognostic value of pretreatment MRI texture features in breast cancer brain metastasis treated with Gamma Knife radiosurgery.
Acta Radiol. 2020 Sep 10:284185120956296.
Zheng Y, Geng D, Yu T, Xia W, She D, Liu L, Yin B PMID: 32910684 DOI: 10.1177/0284185120956296
Stereotactic radiosurgery for brain metastases: A retrospective cohort study comparing treatment results between two lung cancer patient age groups, 75 years or older vs 65-74 years.
Lung Cancer. 2020 Aug 18;149:103-112.
Yamamoto M, Serizawa T, Sato Y, Higuchi Y, Kasuya H, Barfod BE PMID: 33007676 DOI: 10.1016/j.lungcan.2020.07.037
Cumulative intracranial tumour volume prognostic assessment: a new predicting score index for patients with brain metastases treated by stereotactic radiosurgery.
Clin Exp Metastasis. 2020 Aug;37(4):499-508.
Donofrio CA, Cavalli A, Gemma M, Riccio L, Donofrio A, Panni P, Ferrari da Passano C, Del Vecchio A, Bolognesi A, Soffietti R, Mortini P
PMID: 32430649 DOI: 10.1007/s10585-020-10037-z
Gamma Knife Surgery for Brain Metastases from Uterine Malignant Tumor.
World Neurosurg. 2020 Jul;139:e363-e372. Ogino A, Hirai T, Serizawa T, Yoshino A
PMID: 32305598 DOI: 10.1016/j.wneu.2020.03.225
Identification and Management of Progressive Enhancement After Radiation Therapy for Brain Metastases: Results from a Neurosurgical Survey.
World Neurosurg. 2020 Jul;139:e526-e540. Semonche A, Patel NV, Yang I, Danish SF
PMID: 32311550 DOI: 10.1016/j.wneu.2020.04.04
Treating Brain Metastases from Breast Cancer: Outcomes after Stereotactic Radiosurgery.
Clin Oncol (R Coll Radiol). 2020 Jun;32(6):390-396.
Wilson TG, Robinson T, MacFarlane C, Spencer T, Herbert C, Wade L, Reed H, Braybrooke JP
PMID: 32131980 DOI: 10.1016/j.clon.2020.02.007
Pre-stereotactic radiosurgery neutrophil-to-lymphocyte ratio is a predictor of the prognosis for brain metastases.
J Neurooncol. 2020 May;147(3):691-700. Zhang L, Hu Y, Chen W, Tian Y, Xie Y, Chen J
PMID: 32253715 DOI: 10.1007/s11060-020-03477-w
Temporal Change in Tumor Volume Following Stereotactic Radiosurgery to a Single Brain Metastasis.
World neurosurgery. 2020;136:e328-e333
Goethe EA, Rao G, Harvey A, Mesfin FB, Li M, Mahajan A, Ye J, Suki D PMID: 31917308 DOI: 10.1016/j.wneu.2019.12.16
Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study.
Radiat Oncol. 2020 Mar 25;15(1):70.
Ni M, Jiang A, Liu W, Sheng Y, Zeng H, Liu N, Gao Q, Wang Y, Yu J, Yuan S PMID: 32213185 DOI: 10.1186/s13014-020-01509-3
Adverse Radiation Effect After Hypofractionated Stereotactic Radiosurgery in 5 Daily Fractions for Surgical Cavities and Intact Brain Metastases.
International journal of radiation oncology, biology, physics. 2020;106(4):772-779 Faruqi S, Ruschin M, Soliman H, Myrehaug S, Zeng KL, Husain Z, Atenafu E, Tseng CL, Das S, Perry J, Maralani P, Heyn C, Mainprize T, Sahgal A
PMID: 31928848 DOI: 10.1016/j.ijrobp.2019.12.002
Comparison of two-stage Gamma Knife radiosurgery outcomes for large brain metastases among primary cancers.
Journal of neuro-oncology. 2020;147(1):237-246
Ito D, Aoyagi K, Nagano O, Serizawa T, Iwadate Y, Higuchi Y PMID: 32026433 DOI: 10.1007/s11060-020-03421-y
Three-institution study on applicability of initial brain metastasis velocity for breast cancer brain metastasis patients undergoing stereotactic radiosurgery.
Journal of neuro-oncology. 2020;147(1):177-184
Yamamoto M, Serizawa T, Nagano O, Aoyagi K, Higuchi Y, Sato Y, Kasuya H, Barfod BE
PMID: 31989488 DOI: 10.1007/s11060-020-03412-z
Salvage Gamma Knife radiosurgery for active brain metastases from small- cell lung cancer after whole-brain radiation therapy: a retrospective multi- institutional study (JLGK1701).
Journal of neuro-oncology. 2020;147(1):67-76
Nakazaki K, Yomo S, Kondoh T, Serizawa T, Kenai H, Kawagishi J, Sato S, Nagano O, Aiyama H, Kawai H, Hasegawa T, Iwai Y, Nagatomo Y, Kida Y, Nishigaki M PMID: 31933257 DOI: 10.1007/s11060-020-03397-9
Impact of EGFR mutation and ALK rearrangement on the outcomes of non- small cell lung cancer patients with brain metastasis.
Neuro Oncol. 2020 Feb 20;22(2):267-277.
Balasubramanian SK, Sharma M, Venur VA, Schmitt P, Kotecha R, Chao ST, Suh JH, Angelov L, Mohammadi AM, Vogelbaum MA, Barnett GH, Jia X, Pennell NA, Ahluwalia MS
PMID: 31648302 DOI: 10.1093/neuonc/noz155
Estrogen, Progesterone and HER2 Receptor Discordance Between Primary Tumor and Brain Metastases in Breast Cancer and Its Effect on Treatment and Survival.
Neuro-oncology. 2020;
Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, Nesbit E, Kruser TJ, Chan J, Braunstein S, Lee J, Kirkpatrick JP, Breen W, Brown PD, Shi D, Shih HA, Soliman H, Sahgal A, Shanley R, Sperduto W, Lou E, Everett A, Boggs DH, Masucci L, Roberge D, Remick J, Plichta K, Buatti JM, Jain S, Gaspar LE, Wu CC, Wang TJC, Bryant J, Chuong M, Yu J, Chiang V, Nakano T, Aoyama H, Mehta MP
PMID: 32034917 DOI: 10.1093/neuonc/noaa025
Postoperative stereotactic radiosurgery and hypofractionated radiotherapy for brain metastases using Gamma Knife and CyberKnife: a dual-center analysis.
Journal of neurosurgical sciences. 2020;
Kubler J, Wester-Ebbinghaus M, Wenz F, Stieler F, Bathen B, Mai SK, Wolff R, Hanggi D, Blanck O, Giordano F
PMID: 32031357 DOI: 10.23736/S0390-5616.20.04830-4
Radiomics as prognostic factor in brain metastases treated with Gamma Knife radiosurgery.
Journal of neuro-oncology. 2020;146(3):439-449
Huang CY, Lee CC, Yang HC, Lin CJ, Wu HM, Chung WY, Shiau CY, Guo WY, Pan DH, Peng SJ
PMID: 32020474 DOI: 10.1007/s11060-019-03343-4
The effect of Gamma Knife radiosurgery on large posterior fossa metastases and the associated mass effect from peritumoral edema.
Journal of neurosurgery. 2020;:1-9
Muhsen BA, Joshi KC, Lee BS, Thapa B, Borghei-Razavi H, Jia X, Barnett GH, Chao ST, Mohammadi AM, Suh JH, Vogelbaum MA, Angelov L
PMID: 31978879 DOI: 10.3171/2019.11.JNS191485
Referral Patterns and Outcome of Patients With Synchronous Brain Metastases From Non-small Cell Lung Cancer Treated With Gamma Knife Radiosurgery in a Third-Line Treatment Centre in The Netherlands - A Retrospective Analysis.
Clinical oncology (Royal College of Radiologists (Great Britain)). 2020;32(1):52-59
Ten Berge DMHJ, Aarts MJ, Hanssens PEJ, Beute GN, Aerts JGJV, Kloover JS
PMID: 31345622 DOI: 10.1016/j.clon.2019.07.004
Evidence of dose-response following hypofractionated stereotactic radiotherapy to the cavity after surgery for brain metastases.
Journal of neuro-oncology. 2020;146(2):357-362
Garimall S, Shanker M, Johns E, Watkins T, Olson S, Huo M, Foote MC, Pinkham MB
PMID: 31907796 DOI: 10.1007/s11060-019-03383-w
Impact of brain metastasis velocity on neurologic death for brain metastasis patients experiencing distant brain failure after initial stereotactic radiosurgery.
Journal of neuro-oncology. 2020;146(2):285-292
LeCompte MC, Hughes RT, Farris M, Masters A, Soike MH, Lanier C, Glenn C, Cramer CK, Watabe K, Su J, Ruiz J, Whitlow CT, Wang G, Laxton AW, Tatter SB, Chan MD
PMID: 31894518 DOI: 10.1007/s11060-019-03368-9
2019
Stereotactic Radiosurgery to More Than 10 Brain Metastases: Evidence to Support the Role of Radiosurgery for Ideal Hippocampal Sparing in the Treatment of Multiple Brain Metastases.
World neurosurgery. 2019;135:e174-e180
Susko MS, Garcia MA, Ma L, Nakamura JL, Raleigh DR, Fogh S, Theodosopoulos P, McDermott M, Sneed PK, Braunstein SE
PMID: 31785436 DOI: 10.1016/j.wneu.2019.11.089
Pathologic Correlation of Cellular Imaging Using Apparent Diffusion Coefficient Quantification in Patients with Brain Metastases After Gamma Knife Radiosurgery.
World neurosurgery. 2019;134:e903-e912
Borghei-Razavi H, Sharma M, Emch T, Krivosheya D, Lee B, Muhsen B, Prayson R, Obuchowski N, Barnett GH, Vogelbaum MA, Chao ST, Suh JH, Mohammadi AM, Angelov L
PMID: 31733389 DOI: 10.1016/j.wneu.2019.11.037
Extent of surrounding edema does not correlate with acute complications after radiosurgery for melanoma brain metastases.
Journal of neuro-oncology. 2019;145(3):581-585
Jardim A, Scott J, Drew Z, Foote MC, Sadasivan AP, Hall B, Olson SL, Shanker M, Pinkham MB
PMID: 31691060 DOI: 10.1007/s11060-019-03330-9
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors.
The oncologist. 2019;24(12):e1417-e1425
Lee JH, Chen HY, Hsu FM, Chen JS, Liao WY, Shih JY, Yu CJ, Chen KY, Tsai TH, Yang JC
PMID: 31127020 DOI: 10.1634/theoncologist.2019-0152
Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases.
Journal of neuro-oncology. 2019;145(3):551-559
Iorio-Morin C, Mercure-Cyr R, Figueiredo G, Touchette CJ, Masson-Cote L, Mathieu D
PMID: 31667732 DOI: 10.1007/s11060-019-03323-8
Cognitive functioning and predictors thereof in patients with 1-10 brain metastases selected for stereotactic radiosurgery.
Journal of neuro-oncology. 2019;145(2):265-276
Schimmel WCM, Gehring K, Hanssens PEJ, Sitskoorn MM
PMID: 31552588 DOI: 10.1007/s11060-019-03292-y
Single- versus 2-session Gamma Knife surgery for symptomatic midsize brain metastases: a propensity score-matched analysis.
Journal of neurosurgery. 2019;:1-9
Yomo S, Oda K, Oguchi K
PMID: 31628290 DOI: 10.3171/2019.7.JNS191193
Do brain mets grow while you wait? A volumetric natural history assessment of brain metastases from time of diagnosis to Gamma Knife treatment.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2019;68:117-122
Plunkett RJ, Barone TA, Brady WE, Attwood KM, Prasad D
PMID: 31340886 DOI: 10.1016/j.jocn.2019.07.019
Single-fraction versus hypofractionated stereotactic radiosurgery for medium-sized brain metastases of 2.5 to 3 cm.
Journal of neuro-oncology. 2019;145(1):49-56
Chon H, Yoon K, Lee D, Kwon DH, Cho YH
PMID: 31420793 DOI: 10.1007/s11060-019-03265-1
The impact of EGFR-TKI use on clinical outcomes of lung adenocarcinoma patients with brain metastases after Gamma Knife radiosurgery: a propensity score-matched analysis based on extended JLGK0901 dataset (JLGK0901- EGFR-TKI).
Journal of neuro-oncology. 2019;145(1):151-157
Yomo S, Serizawa T, Yamamoto M, Higuchi Y, Sato Y, Shuto T, Akabane A, Jokura H, Kawagishi J, Aoyama H
PMID: 31487030 DOI: 10.1007/s11060-019-03282-0
Outcome of three-fraction Gamma Knife radiosurgery for brain metastases according to fractionation scheme: preliminary results.
Journal of neuro-oncology. 2019;145(1):65-74
Jeon C, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI
PMID: 31446529 DOI: 10.1007/s11060-019-03267-z
Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA).
Clinical and translational radiation oncology. 2019;18:39-45
Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu JB, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney NA, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP
PMID: 31341974 DOI: 10.1016/j.ctro.2019.06.007
Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primaries.
Neuro-oncology practice. 2019;6(5):402-409
Lanier CM, Hughes R, Ahmed T, LeCompte M, Masters AH, Petty WJ, Ruiz J, Triozzi P, Su J, O’Neill S, Watabe K, Cramer CK, Laxton AW, Tatter SB, Wang G, Whitlow C, Chan MD
PMID: 31555455 DOI: 10.1093/nop/npz004
Multidimensional assessment of fatigue in patients with brain metastases before and after Gamma Knife radiosurgery.
Journal of neuro-oncology. 2019;144(2):377-384
Verhaak E, Schimmel WCM, Sitskoorn MM, Bakker M, Hanssens PEJ, Gehring K
PMID: 31350667 DOI: 10.1007/s11060-019-03240-w
Stereotactic radiosurgery in elderly patients with brain metastases: comparison with non-elderly patients using database of a multi-institutional prospective observational study (JLGK0901-Elderly).
Journal of neuro-oncology. 2019;144(2):393-402
Higuchi Y, Yamamoto M, Serizawa T, Sato Y, Shuto T, Akabane A, Jokura H, Yomo S, Nagano O, Kawagishi J, Yamanaka K, Aoyama H
PMID: 31338786 DOI: 10.1007/s11060-019-03242-8
Outcome evaluation of patients treated with fractionated Gamma Knife radiosurgery for large (> 3 cm) brain metastases: a dose-escalation study.
Journal of neurosurgery. 2019;:1-10
Kim KH, Kong DS, Cho KR, Lee MH, Choi JW, Seol HJ, Kim ST, Nam DH, Lee JI
PMID: 31419791 DOI: 10.3171/2019.5.JNS19222
Clinical Outcomes of Upfront Stereotactic Radiosurgery Alone for Patients With 5 to 15 Brain Metastases.
Neurosurgery. 2019;85(2):257-263
Hughes RT, McTyre ER, LeCompte M, Cramer CK, Munley MT, Laxton AW, Tatter SB, Ruiz J, Pasche B, Watabe K, Chan MD
PMID: 29982831 DOI: 10.1093/neuros/nyy276
Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi- Institutional Experience.
International journal of radiation oncology, biology, physics. 2019;104(5):1091-1098
Hughes RT, Masters AH, McTyre ER, Farris MK, Chung C, Page BR, Kleinberg LR, Hepel J, Contessa JN, Chiang V, Ruiz J, Watabe K, Su J, Fiveash JB, Braunstein S, Chao S, Attia A, Ayala-Peacock DN, Chan MD
PMID: 30959122 DOI: 10.1016/j.ijrobp.2019.03.052
Primary or salvage stereotactic radiosurgery for brain metastatic small cell lung cancer.
Journal of neuro-oncology. 2019;144(1):217-225
Faramand A, Niranjan A, Kano H, Flickinger J, Lunsford LD
PMID: 31230250 DOI: 10.1007/s11060-019-03224-w
Stereotactic radiosurgery with and without checkpoint inhibition for patients with metastatic non-small cell lung cancer to the brain: a matched cohort study.
Journal of neurosurgery. 2019;:1-8
Shepard MJ, Xu Z, Donahue J, Eluvathingal Muttikkal TJ, Cordeiro D, Hansen L, Mohammed N, Gentzler RD, Larner J, Fadul CE, Sheehan JP
PMID: 31349225 DOI: 10.3171/2019.4.JNS19822
Preoperative Dural Contact and Recurrence Risk After Surgical Cavity Stereotactic Radiosurgery for Brain Metastases: New Evidence in Support of Consensus Guidelines.
Advances in radiation oncology. 2019;4(3):458-465
Susko M, Yu Y, Ma L, Nakamura J, Fogh S, Raleigh DR, Golden E, Theodosopoulos PV, McDermott MW, Sneed PK, Braunstein SE
PMID: 31360800 DOI: 10.1016/j.adro.2019.03.002
Health-related quality of life of patients with brain metastases selected for stereotactic radiosurgery.
Journal of neuro-oncology. 2019;143(3):537-546
Verhaak E, Gehring K, Hanssens PEJ, Sitskoorn MM
PMID: 31073966 DOI: 10.1007/s11060-019-03186-z
Combination of Trastuzumab Emtansine and Stereotactic Radiosurgery Results in High Rates of Clinically Significant Radionecrosis and Dysregulation of Aquaporin-4.
Clinical cancer research : an official journal of the American Association for Cancer Research. 2019;25(13):3946-3953
Stumpf PK, Cittelly DM, Robin TP, Carlson JA, Stuhr KA, Contreras-Zarate MJ, Lai S, Ormond DR, Rusthoven CG, Gaspar LE, Rabinovitch R, Kavanagh BD, Liu A, Diamond JR, Kabos P, Fisher CM
PMID: 30940654 DOI: 10.1158/1078-0432.CCR-18-2851
Applicability and limitations of a recently-proposed prognostic grading metric, initial brain metastasis velocity, for brain metastasis patients undergoing stereotactic radiosurgery.
Journal of neuro-oncology. 2019;143(3):613-621
Yamamoto M, Aiyama H, Koiso T, Watanabe S, Kawabe T, Sato Y, Higuchi Y, Kasuya H, Barfod BE
PMID: 31140039 DOI: 10.1007/s11060-019-03199-8
The case for radiosurgery for brainstem metastases.
Journal of neuro-oncology. 2019;143(3):585-595
Winograd E, Rivers CI, Fenstermaker R, Fabiano A, Plunkett R, Prasad D
PMID: 31127508 DOI: 10.1007/s11060-019-03195-y
Tumor Cavity Recurrence after Stereotactic Radiosurgery of Surgically Resected Brain Metastases: Implication of Deviations from Contouring Guidelines.
Stereotactic and functional neurosurgery. 2019;97(1):24-30
McDermott DM, Hack JD, Cifarelli CP, Vargo JA
PMID: 30763944 DOI: 10.1159/000496156
Stereotactic Radiosurgery for Patients with 10 or More Brain Metastases.
Progress in neurological surgery. 2019;34:110-124
Yamamoto M, Higuchi Y, Sato Y, Aiyama H, Kasuya H, Barfod BE
PMID: 31096244 DOI: 10.1159/000493056
Epidermal growth factor receptor mutations: association with favorable local tumor control following Gamma Knife radiosurgery in patients with non- small cell lung cancer and brain metastases.
Journal of neurosurgery. 2019;:1-8
Lee CC, Hsu SPC, Lin CJ, Wu HM, Chen YW, Luo YH, Chiang CL, Hu YS, Chung WY, Shiau CY, Guo WY, Hung-Chi Pan D, Yang HC
PMID: 31226692 DOI: 10.3171/2019.4.JNS19446
Single-Session versus Multisession Gamma Knife Radiosurgery for Large Brain Metastases from Non-Small Cell Lung Cancer: A Retrospective Analysis.
Stereotactic and functional neurosurgery. 2019;97(2):94-100
Park K, Kim JW, Chung HT, Paek SH, Kim DG
PMID: 31117101 DOI: 10.1159/000496154
Stereotactic radiosurgery for the treatment of brain metastasis from gastrointestinal primary cancers.
Journal of radiosurgery and SBRT. 2019;6(1):27-34
Paudel N, Helenowski I, Kane L, Sachdev S, Bloch O, Tate M, Chandler JP, Kruser TJ
PMID: 30775072 DOI:
Stereotactic Radiosurgery for Patients with 10 or More Brain Metastases.
Progress in neurological surgery. 2019;34:110-124
Yamamoto M, Higuchi Y, Sato Y, Aiyama H, Kasuya H, Barfod BE
PMID: 31096244 DOI: 10.1159/000493056
Lymphopenia predicts response to stereotactic radiosurgery in lung cancer patients with brain metastases.
Journal of neuro-oncology. 2019;143(2):337-347
Li YD, Lamano JB, Kaur G, Lamano JB, Veliceasa D, Biyashev D, Kruser T, Bloch O
PMID: 30982197 DOI: 10.1007/s11060-019-03169-0
Gamma Knife Radiosurgery for the Management of More Than 15 Cerebral Metastases.
World neurosurgery. 2019;126:e989-e997
Bowden G, Faramand A, Niranjan A, Lunsford LD, Monaco E 3rd
PMID: 30876993 DOI: 10.1016/j.wneu.2019.03.019
Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?
Translational research : the journal of laboratory and clinical medicine. 2019;208:63-72
Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu J, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney N, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP
PMID: 30885538 DOI: 10.1016/j.trsl.2019.02.011
Volumetric changes of intracranial metastases during the course of fractionated stereotactic radiosurgery and significance of adaptive planning.
Journal of neurosurgery. 2019;:1-6
Lee MH, Kim KH, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI
PMID: 31151111 DOI: 10.3171/2019.3.JNS183130
Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis.
Neuro-oncology. 2019;21(5):659-668
Kim JM, Miller JA, Kotecha R, Chao ST, Ahluwalia MS, Peereboom DM, Mohammadi AM, Barnett GH, Murphy ES, Vogelbaum MA, Angelov L, Abraham J, Moore H, Budd GT, Suh JH
PMID: 30726965 DOI: 10.1093/neuonc/noz006
Salvage Stereotactic Radiosurgery in Breast Cancer Patients with Multiple Brain Metastases.
World neurosurgery. 2019;125:e479-e486
Perez JL, Ozpinar A, Kano H, Phan B, Niranjan A, Lunsford LD
PMID: 30710716 DOI: 10.1016/j.wneu.2019.01.108
Comparison between stereotactic radiosurgery and whole-brain radiotherapy for 10-20 brain metastases from non-small cell lung cancer.
Molecular and clinical oncology. 2019;10(5):560-566
Mizuno T, Takada K, Hasegawa T, Yoshida T, Murotani K, Kobayashi H, Sakurai T, Yamashita Y, Akazawa N, Kojima E
PMID: 30967951 DOI: 10.3892/mco.2019.1830
Local tumor progression treated with Gamma Knife radiosurgery: differences between patients with 2-4 versus 5-10 brain metastases based on an update of a multi-institutional prospective observational study (JLGK0901).
Journal of neurosurgery. 2019;:1-10
Serizawa T, Yamamoto M, Higuchi Y, Sato Y, Shuto T, Akabane A, Jokura H, Yomo S, Nagano O, Kawagishi J, Yamanaka K
PMID: 31026833 DOI: 10.3171/2019.1.JNS183085
Volume not number of metastases: Gamma Knife radiosurgery management of intracranial lesions from an Australian perspective.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2019;133:43-49
Izard MA, Moutrie V, Rogers JM, Beath K, Grace M, Karle B, Ho A, Fuller JW
PMID: 30935580 DOI: 10.1016/j.radonc.2018.12.018
Stereotactic Radiosurgery for Multiple Brain Metastases From Renal-Cell Carcinoma.
Clinical genitourinary cancer. 2019;17(2):e273-e280
Wardak Z, Christie A, Bowman A, Stojadinovic S, Nedzi L, Barnett S, Patel T, Mickey B, Whitworth T, Hannan R, Brugarolas J, Timmerman R
PMID: 30595522 DOI: 10.1016/j.clgc.2018.11.006
BRAF V600 Mutation and BRAF Kinase Inhibitors in Conjunction With Stereotactic Radiosurgery for Intracranial Melanoma Metastases: A Multicenter Retrospective Study.
Neurosurgery. 2019;84(4):868-880
Mastorakos P, Xu Z, Yu J, Hess J, Qian J, Chatrath A, Taylor DG, Kondziolka D, Warnick R, Chiang V, Sheehan J
PMID: 29846702 DOI: 10.1093/neuros/nyy203
Efficacy of Gamma Knife radiosurgery in brain metastases of primary gynecological tumors.
Journal of neuro-oncology. 2019;142(2):283-290
Sadik ZHA, Beerepoot LV, Hanssens PEJ
PMID: 30666465 DOI: 10.1007/s11060-019-03094-2
Symptomatic radiation necrosis in brain metastasis patients treated with stereotactic radiosurgery and immunotherapy.
Clinical neurology and neurosurgery. 2019;179:14-18
Weingarten N, Kruser TJ, Bloch O
PMID: 30784894 DOI: 10.1016/j.clineuro.2019.02.010
Breast cancer patients with brain metastasis undergoing GKRS.
Breast cancer (Tokyo, Japan). 2019;26(2):147-153
Abu-Khalaf M, Muralikrishnan S, Hatzis C, Canchi D, Yu JB, Chiang V
PMID: 30182250 DOI: 10.1007/s12282-018-0903-3
Clinical efficacy and safety evaluation of pemetrexed combined with radiotherapy in treatment of patients with lung adenocarcinoma brain metastasis.
Oncology letters. 2019;17(3):2874-2880
Zhang G, Zeng R, Wang K, A Y, Li L, Gong K
PMID: 30854063 DOI: 10.3892/ol.2019.9894
Validity of a Recently Proposed Prognostic Grading Index, Brain Metastasis Velocity, for Patients With Brain Metastasis Undergoing Multiple Radiosurgical Procedures.
International journal of radiation oncology, biology, physics. 2019;103(3):631-637
Yamamoto M, Aiyama H, Koiso T, Watanabe S, Kawabe T, Sato Y, Higuchi Y, Kasuya H, Barfod BE
PMID: 30395905 DOI: 10.1016/j.ijrobp.2018.10.036
Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose.
Neuro-oncology. 2019;21(2):242-251
Moraes FY, Winter J, Atenafu EG, Dasgupta A, Raziee H, Coolens C, Millar BA, Laperriere N, Patel M, Bernstein M, Kongkham P, Zadeh G, Conrad T, Chung C, Berlin A, Shultz DB
PMID: 30265328 DOI: 10.1093/neuonc/noy159
Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases.
Journal of neurosurgery. 2019;132(2):503-511
Parsai S, Miller JA, Juloori A, Chao ST, Kotecha R, Mohammadi AM, Ahluwalia MS, Murphy ES, Barnett GH, Vogelbaum MA, Angelov L, Peereboom DM, Suh JH
PMID: 30738402 DOI: 10.3171/2018.10.JNS182340
Factors influencing the outcome of stereotactic radiosurgery in patients with five or more brain metastases.
Current oncology (Toronto, Ont.). 2019;26(1):e64-e69
Hamel-Perreault E, Mathieu D, Masson-Cote L
PMID: 30853811 DOI: 10.3747/co.25.4244
Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial.
JAMA oncology. 2019;5(2):243-247
Churilla TM, Chowdhury IH, Handorf E, Collette L, Collette S, Dong Y, Alexander BM, Kocher M, Soffietti R, Claus EB, Weiss SE
PMID: 30419088 DOI: 10.1001/jamaoncol.2018.4610
Gamma Knife Radiosurgery for Metastatic Brain Tumors from Cancer of Unknown Primary.
World neurosurgery. 2019;122:e1465-e1471
Matsunaga S, Shuto T, Kobayashi N
PMID: 30468925 DOI: 10.1016/j.wneu.2018.11.086
Low-dose Gamma Knife radiosurgery plus whole-brain radiation therapy for patients with 5 or more brain metastases with or without meningeal dissemination.
International journal of clinical oncology. 2019;24(2):161-167
Miyakawa A, Shibamoto Y, Takemoto S, Hirai T, Serizawa T
PMID: 30099697 DOI: 10.1007/s10147-018-1339-7
Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases.
Journal of neurosurgery. 2019;:1-9
Juloori A, Miller JA, Parsai S, Kotecha R, Ahluwalia MS, Mohammadi AM, Murphy ES, Suh JH, Barnett GH, Yu JS, Vogelbaum MA, Rini B, Garcia J, Stevens GH, Angelov L, Chao ST
PMID: 30660120 DOI: 10.3171/2018.8.JNS182100
Radiological Kinetics of Brain Metastases and Clinical Implications for Patients Treated With Stereotactic Radiosurgery.
Clinical oncology (Royal College of Radiologists (Great Britain)). 2019;31(1):34-40
Nicholls LW, Pinkham MB, Bernard A, Lusk R, Watkins T, Hall B, Olson S, Foote MC
PMID: 30279038 DOI: 10.1016/j.clon.2018.09.005
2018
Quality of life outcomes for brain metastasis patients treated with stereotactic radiosurgery: pre-procedural predictive factors from a prospective national registry.
Journal of neurosurgery. 2018;131(6):1848-1854
Sheehan JP, Grills I, Chiang VL, Dong H, Berg A, Warnick RE, Kondziolka D, Kavanagh B
PMID: 30579284 DOI: 10.3171/2018.8.JNS181599
The influence of histology on the response of brain metastases to Gamma Knife radiosurgery: a propensity score-matched study.
Acta neurochirurgica. 2018;160(12):2379-2386
Kim KH, Lee MH, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI
PMID: 30413940 DOI: 10.1007/s00701-018-3726-2
Clinical significance of conformity index and gradient index in patients undergoing stereotactic radiosurgery for a single metastatic tumor.
Journal of neurosurgery. 2018;129(Suppl1):103-110
Aiyama H, Yamamoto M, Kawabe T, Watanabe S, Koiso T, Sato Y, Higuchi Y, Ishikawa E, Yamamoto T, Matsumura A, Kasuya H
PMID: 30544326 DOI: 10.3171/2018.6.GKS181314
Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
Journal of neurosurgery. 2018;129(Suppl1):86-94
Shuto T, Akabane A, Yamamoto M, Serizawa T, Higuchi Y, Sato Y, Kawagishi J, Yamanaka K, Jokura H, Yomo S, Nagano O, Aoyama H
PMID: 30544291 DOI: 10.3171/2018.7.GKS181378
Three-stage Gamma Knife treatment for metastatic brain tumors larger than 10 cm3: a 2-institute study including re-analyses of earlier results using competing risk analysis.
Journal of neurosurgery. 2018;129(Suppl1):77-85
Yamamoto M, Higuchi Y, Serizawa T, Kawabe T, Nagano O, Sato Y, Koiso T, Watanabe S, Aiyama H, Kasuya H
PMID: 30544297 DOI: 10.3171/2018.7.GKS181392
Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: a 2-institution study.
Journal of neurosurgery. 2018;129(Suppl1):95-102
Yamamoto M, Serizawa T, Higuchi Y, Nagano O, Aiyama H, Koiso T, Watanabe S, Kawabe T, Sato Y, Kasuya H
PMID: 30544299 DOI: 10.3171/2018.7.GKS181458
Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastases.
Journal of neuro-oncology. 2018;140(3):749-756
Dohm AE, Hughes R, Wheless W, Lecompte M, Lanier C, Ruiz J, Watabe K, Xing F, Su J, Cramer C, Laxton A, Tatter S, Chan MD
PMID: 30367382 DOI: 10.1007/s11060-018-03008-8
Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool.
Neuro-oncology. 2018;20(12):1652-1660
Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP
PMID: 30418657 DOI: 10.1093/neuonc/noy099
Complications after stereotactic radiosurgery for brain metastases: Incidences, correlating factors, treatments and outcomes.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2018;129(2):364-369
Aiyama H, Yamamoto M, Kawabe T, Watanabe S, Koiso T, Sato Y, Higuchi Y, Ishikawa E, Yamamoto T, Matsumura A, Kasuya H, Barfod BE
PMID: 30293644 DOI: 10.1016/j.radonc.2018.08.018
Evolution in the role of stereotactic radiosurgery in patients with multiple brain metastases: An international survey.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2018;57:6-12
Dutta SW, Sheehan JP, Niranjan A, Lunsford LD, Trifiletti DM
PMID: 30145088 DOI: 10.1016/j.jocn.2018.08.029
Tailored Treatment Options for Patients with Brain Metastases by a Relocatable Frame System with Gamma Knife Radiosurgery.
World neurosurgery. 2018;119:e338-e348
Ye K, Samuthrat T, Hu C, Tong Y
PMID: 30059780 DOI: 10.1016/j.wneu.2018.07.157
Immune checkpoint inhibitors and radiosurgery for newly diagnosed melanoma brain metastases.
Journal of neuro-oncology. 2018;140(1):55-62
Robin TP, Breeze RE, Smith DE, Rusthoven CG, Lewis KD, Gonzalez R, Brill A, Saiki R, Stuhr K, Gaspar LE, Karam SD, Raben D, Kavanagh BD, Nath SK, Liu AK
PMID: 29909499 DOI: 10.1007/s11060-018-2930-5
Stereotactic radiosurgery for brain metastases from malignant melanoma and the impact of hemorrhagic metastases.
Journal of neuro-oncology. 2018;140(1):83-88
Bauer-Nilsen K, Trifiletti DM, Chatrath A, Ruiz-Garcia H, Marchan E, Peterson J, May BC, Sheehan JP
PMID: 29926319 DOI: 10.1007/s11060-018-2933-2
Efficacy of brain radiotherapy plus EGFR-TKI for EGFR-mutated non-small cell lung cancer patients who develop brain metastasis.
Archives of medical science : AMS. 2018;14(6):1298-1307
Wang W, Song Z, Zhang Y
PMID: 30393484 DOI: 10.5114/aoms.2018.78939
Comparison of treatment results between 3- and 2-stage Gamma Knife radiosurgery for large brain metastases: a retrospective multi-institutional study.
Journal of neurosurgery. 2018;131(1):227-237
Serizawa T, Higuchi Y, Yamamoto M, Matsunaga S, Nagano O, Sato Y, Aoyagi K, Yomo S, Koiso T, Hasegawa T, Nakazaki K, Moriki A, Kondoh T, Nagatomo Y, Okamoto H, Kohda Y, Kawai H, Shidoh S, Shibazaki T, Onoue S, Kenai H, Inoue A, Mori H
PMID: 30192195 DOI: 10.3171/2018.4.JNS172596
Repeat Stereotactic Radiosurgery for Recurred Metastatic Brain Tumors.
Journal of Korean Neurosurgical Society. 2018;61(5):633-639
Kim IY, Jung S, Jung TY, Moon KS, Jang WY, Park JY, Song TW, Lim SH
PMID: 30064202 DOI: 10.3340/jkns.2017.0238
Absolute CBV for the differentiation of recurrence and radionecrosis of brain metastases after Gamma Knife radiotherapy: a comparison with relative CBV.
Clinical radiology. 2018;73(8):758.e1-758.e7
Wang B, Zhao B, Zhang Y, Ge M, Zhao P, Na Sun, Li C, Pang Q, Xu S, Liu Y
PMID: 29764622 DOI: 10.1016/j.crad.2018.04.006
Long-Term Survivorship Following Stereotactic Radiosurgery Alone for Brain Metastases: Risk of Intracranial Failure and Implications for Surveillance and Counseling.
Neurosurgery. 2018;83(2):203-209
Gogineni E, Vargo JA, Glaser SM, Flickinger JC, Burton SA, Engh JA, Amankulor NM, Beriwal S, Quinn AE, Ozhasoglu C, Heron DE
PMID: 28945873 DOI: 10.1093/neuros/nyx376
Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases >/= 2 cm.
Journal of neurosurgery. 2018;129(2):366-382
Angelov L, Mohammadi AM, Bennett EE, Abbassy M, Elson P, Chao ST, Montgomery JS, Habboub G, Vogelbaum MA, Suh JH, Murphy ES, Ahluwalia MS, Nagel SJ, Barnett GH
PMID: 28937324 DOI: 10.3171/2017.3.JNS162532
Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis.
Journal of neurosurgery. 2018;129(2):354-365
Zubatkina I, Ivanov P
PMID: 28841116 DOI: 10.3171/2017.1.JNS162075
Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases.
International journal of radiation oncology, biology, physics. 2018;101(4):845-853
Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP
PMID: 29976497 DOI: 10.1016/j.ijrobp.2018.04.006
Evaluation of Prognostic Factors for Early Mortality After Stereotactic Radiosurgery for Brain Metastases: a Single Institutional Retrospective Review.
Neurosurgery. 2018;83(1):128-136
Bennett EE, Vogelbaum MA, Barnett GH, Angelov L, Chao S, Murphy E, Yu J, Suh JH, Elson P, Stevens GHJ, Mohammadi AM
PMID: 28673040 DOI: 10.1093/neuros/nyx346
Evaluation of new lesions and symptoms after Gamma Knife radiosurgery for brain metastases: a retrospective cohort study.
Acta neurochirurgica. 2018;160(7):1461-1471
Nakazaki K, Nishigaki M
PMID: 29633031 DOI: 10.1007/s00701-018-3524-x
Staged Stereotactic Radiosurgery for Large Brain Metastases: Local Control and Clinical Outcomes of a One-Two Punch Technique.
Neurosurgery. 2018;83(1):114-121
Dohm A, McTyre ER, Okoukoni C, Henson A, Cramer CK, LeCompte MC, Ruiz J, Munley MT, Qasem S, Lo HW, Xing F, Watabe K, Laxton AW, Tatter SB, Chan MD
PMID: 28973432 DOI: 10.1093/neuros/nyx355
Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Journal of neurosurgery. 2018;129(1):71-83
Bragstad S, Flatebo M, Natvig GK, Eide GE, Skeie GO, Behbahani M, Pedersen PH, Enger PO, Skeie BS
PMID: 28820304 DOI: 10.3171/2017.2.JNS161659
Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome.
Journal of neurosurgery. 2018;129(1):50-59
Kotecha R, Miller JA, Venur VA, Mohammadi AM, Chao ST, Suh JH, Barnett GH, Murphy ES, Funchain P, Yu JS, Vogelbaum MA, Angelov L, Ahluwalia MS
PMID: 28799876 DOI: 10.3171/2017.1.JNS162797
Predictors for a further local in-brain progression after re-craniotomy of locally recurrent cerebral metastases.
Neurosurgical review. 2018;41(3):813-823
Kamp MA, Fischer I, Dibue-Adjei M, Munoz-Bendix C, Cornelius JF, Steiger HJ, Slotty PJ, Turowski B, Rapp M, Sabel M
PMID: 29260342 DOI: 10.1007/s10143-017-0931-z
The concept of rapid rescue radiosurgery in the acute management of critically located brain metastases: A retrospective short-term outcome analysis.
Surgical neurology international. 2018;9:218
Sinclair G, Benmakhlouf H, Brigui M, Maeurer M, Dodoo E
PMID: 30505620 DOI: 10.4103/sni.sni_480_17
Gamma Knife Radiosurgery for Metastatic Brain Tumors from Malignant Melanomas: A Japanese Multi-Institutional Cooperative and Retrospective Cohort Study (JLGK1501).
Stereotactic and functional neurosurgery. 2018;96(3):162-171
Matsunaga S, Shuto T, Yamamoto M, Yomo S, Kondoh T, Kobayashi T, Sato M, Okamoto H, Serizawa T, Nagano O, Kenai H, Obara T, Iwai Y, Yasuda S, Hasegawa T, Kubo K, Shidoh S, Mori K, Hayashi M, Inoue A, Onoue S, Gondo M
PMID: 29969770 DOI: 10.1159/000489948
Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
PloS one. 2018;13(6):e0198692
Balermpas P, Stera S, Muller von der Grun J, Loutfi-Krauss B, Forster MT, Wagner M, Keller C, Rodel C, Seifert V, Blanck O, Wolff R
PMID: 29874299 DOI: 10.1371/journal.pone.0198692
Potential prognostic markers for survival and neurologic death in patients with breast cancer brain metastases who receive upfront SRS alone.
Journal of radiosurgery and SBRT. 2018;5(4):277-283
Shenker RF, Hughes RT, McTyre ER, Lanier C, Lo HW, Metheny-Barlow L, Su J, Thomas A, Brown DR, Avery T, Pasche B, Cramer CK, Laxton AW, Tatter SB, Watabe K, Chan MD
PMID: 30538888 DOI:
Postcontrast T1 Mapping for Differential Diagnosis of Recurrence and Radionecrosis after Gamma Knife Radiosurgery for Brain Metastasis.
AJNR. American journal of neuroradiology. 2018;39(6):1025-1031
Wang B, Zhang Y, Zhao B, Zhao P, Ge M, Gao M, Ding F, Xu S, Liu Y
PMID: 29724761 DOI: 10.3174/ajnr.A5643
Validation of the Chowdhury overall survival score in patients with melanoma brain metastasis treated with Gamma Knife Radiosurgery.
Journal of neuro-oncology. 2018;138(2):391-399
Rodenburg RJ, Hanssens PE, Ho VKY, Beerepoot LV
PMID: 29470692 DOI: 10.1007/s11060-018-2808-6
Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis.
Journal of neurosurgery. 2018;130(3):804-811
Ahluwalia M, Barnett GH, Deng D, Tatter SB, Laxton AW, Mohammadi AM, Leuthardt E, Chamoun R, Judy K, Asher A, Essig M, Dietrich J, Chiang VL
PMID: 29726782 DOI: 10.3171/2017.11.JNS171273
Survival of Patients With Multiple Intracranial Metastases Treated With Stereotactic Radiosurgery: Does the Number of Tumors Matter?
American journal of clinical oncology. 2018;41(5):425-431
Knoll MA, Oermann EK, Yang AI, Paydar I, Steinberger J, Collins B, Collins S, Ewend M, Kondziolka D
PMID: 27258677 DOI: 10.1097/COC.0000000000000299
Impacts of EGFR-mutation status and EGFR-TKI on the efficacy of stereotactic radiosurgery for brain metastases from non-small cell lung adenocarcinoma: A retrospective analysis of 133 consecutive patients.
Lung cancer (Amsterdam, Netherlands). 2018;119:120-126
Yomo S, Oda K
PMID: 29656746 DOI: 10.1016/j.lungcan.2018.03.013
Identifying candidates for Gamma Knife radiosurgery among elderly patients with brain metastases.
Journal of neuro-oncology. 2018;137(3):559-565
Roh TH, Choi MS, You N, Jeong D, Jang AH, Seo MR, Lee SR, Kim SH
PMID: 29327172 DOI: 10.1007/s11060-018-2745-4
Postoperative radiosurgery for the treatment of metastatic brain tumor: Evaluation of local failure and leptomeningeal disease.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2018;49:48-55
Foreman PM, Jackson BE, Singh KP, Romeo AK, Guthrie BL, Fisher WS, Riley KO, Markert JM, Willey CD, Bredel M, Fiveash JB
PMID: 29248376 DOI: 10.1016/j.jocn.2017.12.009
The growing importance of lesion volume as a prognostic factor in patients with multiple brain metastases treated with stereotactic radiosurgery.
Cancer medicine. 2018;7(3):757-764
Routman DM, Bian SX, Diao K, Liu JL, Yu C, Ye J, Zada G, Chang EL
PMID: 29441722 DOI: 10.1002/cam4.1352
Multi-institutional competing risks analysis of distant brain failure and salvage patterns after upfront radiosurgery without whole brain radiotherapy for brain metastasis.
Annals of oncology : official journal of the European Society for Medical Oncology. 2018;29(2):497-503
McTyre E, Ayala-Peacock D, Contessa J, Corso C, Chiang V, Chung C, Fiveash J, Ahluwalia M, Kotecha R, Chao S, Attia A, Henson A, Hepel J, Braunstein S, Chan M
PMID: 29161348 DOI: 10.1093/annonc/mdx740
Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC.
Clinical lung cancer. 2018;19(1):e141-e147
Woody NM, Greer MD, Reddy CA, Videtic GMM, Chao ST, Murphy ES, Suh JH, Angelov L, Barnett GH, Vogelbaum MA, Stephans KL
PMID: 28739316 DOI: 10.1016/j.cllc.2017.06.011
Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery.
Journal of neurosurgery. 2018;128(1):14-22
Kano H, Morales-Restrepo A, Iyer A, Weiner GM, Mousavi SH, Kirkwood JM, Tarhini AA, Flickinger JC, Lunsford LD
PMID: 28106495 DOI: 10.3171/2016.9.JNS161011
Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgery.
Journal of neurosurgery. 2018;128(1):23-31
Wolf A, Kvint S, Chachoua A, Pavlick A, Wilson M, Donahue B, Golfinos JG, Silverman J, Kondziolka D
PMID: 28298015 DOI: 10.3171/2016.10.JNS161036
Local control and overall survival for adjuvant stereotactic radiosurgery in patients with residual or recurrent disease.
Journal of neuro-oncology. 2018;136(2):281-287
Nanda T, Yaeh A, Wu CC, Jani A, Saad S, Qureshi YH, Cauley KA, Lesser J, Cheng SK, Isaacson SR, Sisti MB, Bruce JN, McKhann GM, Sheth SA, Lassman AB, Wang TJC
PMID: 29170908 DOI: 10.1007/s11060-017-2651-1